{"content":"<li class=\"n-box-item date-title\" data-end=\"1560398399\" data-start=\"1560312000\" data-txt=\"Monday, December 23, 2019\">Wednesday, June 12, 2019</li><li class=\"n-box-item sa-box-item\" data-id=\"3470963\" data-ts=\"1560384395\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470963-fang-holdings-completes-separation-from-china-index-holdings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fang Holdings completes separation from China Index Holdings</a></h4><ul>   <li>Fang Holdings (NYSE:<a href='https://seekingalpha.com/symbol/SFUN' title='Fang Holdings Limited'>SFUN</a>) has <a href=\"https://seekingalpha.com/pr/17543189-fang-china-index-announce-completion-separation-way-distribution\" target=\"_blank\">wrapped up its spin-off</a> of real estate service platform China Index Holdings Limited (NASDAQ:<a href='https://seekingalpha.com/symbol/CIH' title='China Index Holdings Limited'>CIH</a>).</li>    <li>That occurred via a dividend distribution of CIH ordinary shares held by Fang to its equity holders.</li>    <li>CIH will now focus on serving the commercial property sector in China, while Fang will keep its business operating a real estate Internet portal serving residential property.</li>    <li>CIHA has appointed four new directors: Huang Yu, Jie Jiao, Robert Ciemniak, and Jeff Xuesong Leng. Vincent Tianquan Mo remains chairman of both companies' boards.</li>    <li>After hours: <a href='https://seekingalpha.com/symbol/CIH' title='China Index Holdings Limited'>CIH</a> <font color=\"green\">+6.3%</font>; <a href='https://seekingalpha.com/symbol/SFUN' title='Fang Holdings Limited'>SFUN</a> <font color=\"green\">+1.9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3470963\" data-linked=\"Fang Holdings completes separation from China Index Holdings\" data-tweet=\"$SFUN $CIH - Fang Holdings completes separation from China Index Holdings https://seekingalpha.com/news/3470963-fang-holdings-completes-separation-from-china-index-holdings?source=tweet\" data-url=\"https://seekingalpha.com/news/3470963-fang-holdings-completes-separation-from-china-index-holdings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470947\" data-ts=\"1560375209\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470947-lulu-rh-and-tlrd-among-after-hour-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">LULU, RH and TLRD among after hour movers</a></h4><ul><li><strong>Gainers: </strong><a href='https://seekingalpha.com/symbol/RH' title='RH'>RH</a> <font color=\"green\">+22.4%</font>. <a href='https://seekingalpha.com/symbol/FRME' title='First Merchants Corporation'>FRME</a> <font color=\"green\">+8.1%</font>. <a href='https://seekingalpha.com/symbol/OXM' title='Oxford Industries, Inc.'>OXM</a> <font color=\"green\">+3.9%</font>. <a href='https://seekingalpha.com/symbol/LULU' title='Lululemon Athletica Inc.'>LULU</a> <font color=\"green\">+3.6%</font>. <a href='https://seekingalpha.com/symbol/CIH' title='China Index Holdings Limited'>CIH</a> <font color=\"green\">+3.1%</font>.</li><li><strong>Losers: </strong><a href='https://seekingalpha.com/symbol/SVRA' title='Savara Inc.'>SVRA</a> <font color=\"red\">-76.6%</font>. <a href='https://seekingalpha.com/symbol/HEB' title='Hemispherx Biopharma, Inc.'>HEB</a> <font color=\"red\">-23.1%</font>. <a href='https://seekingalpha.com/symbol/MCRB' title='Seres Therapeutics, Inc.'>MCRB</a> <font color=\"red\">-14.9%</font><a href='https://seekingalpha.com/symbol/TLRD' title='Tailored Brands, Inc.'>TLRD</a> <font color=\"red\">-7.4%</font>. <a href='https://seekingalpha.com/symbol/BRY' title='Berry Petroleum Corporation'>BRY</a> <font color=\"red\">-3.5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3470947\" data-linked=\"LULU, RH and TLRD among after hour movers\" data-tweet=\"$RH $FRME $OXM - LULU, RH and TLRD among after hour movers https://seekingalpha.com/news/3470947-lulu-rh-and-tlrd-among-after-hour-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3470947-lulu-rh-and-tlrd-among-after-hour-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:33 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470934\" data-ts=\"1560372891\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NEPT\" target=\"_blank\">NEPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470934-neptune-down-9-after-hours-on-fq4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Neptune down 9% after hours on FQ4 results</a></h4><ul><li>Neptune Wellness Solutions (NASDAQ:<a href='https://seekingalpha.com/symbol/NEPT' title='Neptune Wellness Solutions Inc.'>NEPT</a>) <a href=\"https://seekingalpha.com/pr/17542973-neptune-announces-fourth-quarter-results\" target=\"_blank\">reports </a>fiscal Q4 results. Highlights:</li><li>Revenues: $5.7M (-16%); net loss: ($12.4M) (-158%).</li><li>Citing constraints like limited biomass inventory, fiscal Q1 cannabis extraction revenues will be lower than $1M.</li><li>Shares are down <font color=\"red\">9%</font> after hours.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3470892-neptune-wellness-solutions-reports-q4-results\" target=\"_blank\">Neptune Wellness Solutions reports Q4 results</a> (June 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3470934\" data-linked=\"Neptune down 9% after hours on FQ4 results\" data-tweet=\"$NEPT - Neptune down 9% after hours on FQ4 results https://seekingalpha.com/news/3470934-neptune-down-9-after-hours-on-fq4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3470934-neptune-down-9-after-hours-on-fq4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:54 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470930\" data-ts=\"1560372338\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TTPH\" target=\"_blank\">TTPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470930-tetraphase-down-4-after-hours-on-downsizing-plan\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tetraphase down 4% after hours on downsizing plan</a></h4><ul><li>Aimed at maximizing the commercial opportunity for XERAVA (eravacycline), Tetraphase Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/TTPH' title='Tetraphase Pharmaceuticals, Inc.'>TTPH</a>) will eliminate its internal research function, a move expected to save about $8M a year.</li><li>It also plans to explore out-licensing deals for its pipeline.</li><li>Chief Operating Officer Larry Edwards will succeed Guy Macdonald as President &amp; CEO following a transition that will extend until August 1. Mr. Macdonald will remain a board member and will serve as a consultant until December.</li><li>Shares are down <font color=\"red\">4%</font> after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3470930\" data-linked=\"Tetraphase down 4% after hours on downsizing plan\" data-tweet=\"$TTPH - Tetraphase down 4% after hours on downsizing plan https://seekingalpha.com/news/3470930-tetraphase-down-4-after-hours-on-downsizing-plan?source=tweet\" data-url=\"https://seekingalpha.com/news/3470930-tetraphase-down-4-after-hours-on-downsizing-plan\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470923\" data-ts=\"1560371687\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MCRB\" target=\"_blank\">MCRB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470923-seres-therapeutics-launches-60m-stock-offering-shares-down-12-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Seres Therapeutics launches $60M stock offering; shares down 12% after hours</a></h4><ul><li>Thinly traded micro cap Seres Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/MCRB' title='Seres Therapeutics, Inc.'>MCRB</a>) slumps <font color=\"red\">12%</font> after hours in reaction to its <a href=\"https://seekingalpha.com/pr/17543007-seres-therapeutics-inc-announces-proposed-public-offering-common-stock\" target=\"_blank\">$60M public offering</a> of common stock. Price, volume and terms have yet to be announced.</li></ul><div class=\"tiny-share-widget\" data-id=\"3470923\" data-linked=\"Seres Therapeutics launches $60M stock offering; shares down 12% after hours\" data-tweet=\"$MCRB - Seres Therapeutics launches $60M stock offering; shares down 12% after hours https://seekingalpha.com/news/3470923-seres-therapeutics-launches-60m-stock-offering-shares-down-12-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3470923-seres-therapeutics-launches-60m-stock-offering-shares-down-12-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:34 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470916\" data-ts=\"1560371188\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SVRA\" target=\"_blank\">SVRA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470916-savaras-molgradex-flunks-late-stage-apap-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Savara&#39;s Molgradex flunks late-stage aPAP study</a></h4><ul><li>Thinly traded micro cap Savara (NASDAQ:<a href='https://seekingalpha.com/symbol/SVRA' title='Savara Inc.'>SVRA</a>) is poised for a significant down move after <a href=\"https://seekingalpha.com/pr/17542984-savara-announces-results-impala-phase-3-study-molgradex-treatment-autoimmune-alveolar\" target=\"_blank\">announcing</a> that its Phase 3 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT02702180?lead=savara&amp;phase=2&amp;rank=3\" target=\"_blank\">IMPALA</a>, evaluating lead drug Molgradex in patients with autoimmune alveolar pulmonary proteinosis (aPAP) failed to sufficiently separate from placebo.</li><li>The study did not achieve the primary endpoint of a statistically significant change from baseline to week 24 in a measure of low blood oxygen called alveolar-arterial oxygen gradient (A-aDO<sub>2</sub>). Specifically, average A-aDO<sub>2 </sub>improved 12.1 mmHg in the treatment group compared to 8.8 mmHg in the placebo arm (p=0.17), falling short of statistical significance.</li><li>There was a statistically valid separation from control for a secondary endpoint of a patient-reported outcomes/quality of life scale called SGRQ. Another secondary endpoint, the six-minute walk test, failed to adequately separate from control.</li><li>On a positive note, the safety profile was on par with placebo.</li><li><a href=\"https://rarediseases.info.nih.gov/diseases/7499/autoimmune-pulmonary-alveolar-proteinosis\" target=\"_blank\">APAP </a>is a rare autoimmune disorder in which a surfactant accumulates in the alveoli (tiny air sacs in the lungs) making it difficult to breathe.</li><li>The company plans to meet with the FDA and EMA in the coming months to discuss the data and a path forward.</li><li>Management will host a conference call today at 5:30 pm ET to discuss the results.</li><li>Shares will resume trading at 4:30 pm ET.</li><li><strong>Update</strong>: Shares are down <font color=\"red\">75%</font> after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3470916\" data-linked=\"Savara&#39;s Molgradex flunks late-stage aPAP study\" data-tweet=\"$SVRA - Savara&#39;s Molgradex flunks late-stage aPAP study https://seekingalpha.com/news/3470916-savaras-molgradex-flunks-late-stage-apap-study?source=tweet\" data-url=\"https://seekingalpha.com/news/3470916-savaras-molgradex-flunks-late-stage-apap-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470914\" data-ts=\"1560371111\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LULU\" target=\"_blank\">LULU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470914-comparable-sales-dazzle-lululemon\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Comparable sales dazzle at Lululemon</a></h4><ul> <li>Lululemon (NASDAQ:<a href='https://seekingalpha.com/symbol/LULU' title='Lululemon Athletica Inc.'>LULU</a>) rallies in AH trading after <a href=\"https://seekingalpha.com/pr/17542996-lululemon-athletica-inc-announces-first-quarter-fiscal-2019-results\" target=\"_blank\">lifting</a> its full-year profit view.</li> <li>The company anticipates FY revenue of $3.73B to $3.77B vs. $3.70B to $3.74B prior and $3.77B consensus. EPS of $4.51 to $4.58 is anticipated vs. $4.48 to $4.55 prior and $4.62 consensus.</li><li>Comparable sales were up 16% in Q1 off broad-based momentum to smash the consensus expectation for an 11% increase. The store-only comp was +8%.</li> <li>LULU <font color=\"green\">+2.61%</font> AH to $175.32.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3470894-lululemon-athletica-eps-beats-0_04-beats-revenue\" target=\"_blank\">Lululemon Athletica EPS beats by $0.04, beats on revenue</a> (June 12)</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3470914\" data-linked=\"Comparable sales dazzle at Lululemon\" data-tweet=\"$LULU - Comparable sales dazzle at Lululemon https://seekingalpha.com/news/3470914-comparable-sales-dazzle-lululemon?source=tweet\" data-url=\"https://seekingalpha.com/news/3470914-comparable-sales-dazzle-lululemon\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470912\" data-ts=\"1560370768\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XLE\" target=\"_blank\">XLE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470912-u-s-oil-finishes-4-lower-on-crude-build-demand-fears\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">U.S. oil finishes 4% lower on crude build, demand fears</a></h4><ul><li>Oil prices sink to their <a href=\"https://www.cnbc.com/2019/06/12/oil-market-opec-supply-cuts-us-crude-inventories-in-focus.html\" target=\"_blank\">lowest settlement in five months</a> after U.S. government data showed a <a href=\"https://seekingalpha.com/news/3470784-crude-inventory-builds-slightly\" target=\"_blank\">large increase in domestic crude inventories</a> for the second week in a row.</li><li>WTI finished <font color=\"red\">-4%</font> to $51.15/bbl, the weakest settlement for a front-month contract since Jan. 14, and Brent <font color=\"red\">-3.7%</font> to $59.97/bbl, its first settlement below $60 since January.</li><li>At 485.5M, U.S. commercial stocks were at their highest since July 2017 and <a href=\"https://www.reuters.com/article/us-global-oil/oil-slumps-4-on-u-s-crude-build-slowing-demand-fears-idUSKCN1TD03H\" target=\"_blank\">~8% above the five-year average for this time of year</a>, according to the Energy Information Administration.</li><li>Concerns over energy demand amid a lack of progress toward a resolution to the U.S.-China trade dispute also <a href=\"https://seekingalpha.com/news/3470691-fears-falling-demand-surging-u-s-stockpiles-send-oil-prices-plunging\" target=\"_blank\">continue to pressure prices</a>.</li><li>WTI is now down 23% from its 2019 high in April, while Brent is trading 20% lower over the same period.</li><li>Energy (<a href='https://seekingalpha.com/symbol/XLE' title='Energy Select Sector SPDR ETF'>XLE</a> <font color=\"red\">-1.4%</font>) was today's poorest performer among the 11 S&amp;P industry sectors, with today's biggest losers including <a href='https://seekingalpha.com/symbol/ROAN' title='Roan Resources, Inc.'>ROAN</a> <font color=\"red\">-17.6%</font>, <a href='https://seekingalpha.com/symbol/SPN' title='Superior Energy Services, Inc.'>SPN</a> <font color=\"red\">-15.3%</font>, <a href='https://seekingalpha.com/symbol/NE' title='Noble Corporation plc'>NE</a> <font color=\"red\">-10.9%</font>, <a href='https://seekingalpha.com/symbol/STNG' title='Scorpio Tankers Inc.'>STNG</a> <font color=\"red\">-9.2%</font>, <a href='https://seekingalpha.com/symbol/SLCA' title='U.S. Silica Holdings, Inc.'>SLCA</a> <font color=\"red\">-8%</font>, <a href='https://seekingalpha.com/symbol/CHK' title='Chesapeake Energy Corporation'>CHK</a> <font color=\"red\">-7.6%</font>, <a href='https://seekingalpha.com/symbol/ECA' title='Encana Corporation'>ECA</a> <font color=\"red\">-6.9%</font>, <a href='https://seekingalpha.com/symbol/DO' title='Diamond Offshore Drilling, Inc.'>DO</a> <font color=\"red\">-6.9%</font>, <a href='https://seekingalpha.com/symbol/RIG' title='Transocean Ltd.'>RIG</a> <font color=\"red\">-6.8%</font>, <a href='https://seekingalpha.com/symbol/XOG' title='Extraction Oil & Gas, Inc.'>XOG</a> <font color=\"red\">-6.8%</font>, <a href='https://seekingalpha.com/symbol/SWN' title='Southwestern Energy Company'>SWN</a> <font color=\"red\">-6.3%,</font> <a href='https://seekingalpha.com/symbol/ESV' title='Ensco Rowan plc'>ESV</a> <font color=\"red\">-5.8%</font>, <a href='https://seekingalpha.com/symbol/HAL' title='Halliburton Company'>HAL</a> <font color=\"red\">-4.5%</font>, <a href='https://seekingalpha.com/symbol/NBL' title='Noble Energy, Inc.'>NBL</a> <font color=\"red\">-4.4%</font>.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UWT' title='VelocityShares 3X Long Crude ETN'>UWT</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Ultra Bloomberg Crude Oil ETF'>UCO</a>, <a href='https://seekingalpha.com/symbol/DWT' title='VelocityShares 3x Inverse Crude Oil ETN'>DWT</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/BNO' title='The United States Brent Oil ETF, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/DBO' title='Invesco DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/USL' title='The United States 12 Month Oil ETF, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/OLO' title='DB Crude Oil Long ETN'>OLO</a>, <a href='https://seekingalpha.com/symbol/SZO' title='DB Crude Oil Short ETN'>SZO</a>, <a href='https://seekingalpha.com/symbol/OLEM' title='iPath Pure Beta Crude Oil ETN'>OLEM</a>, <a href='https://seekingalpha.com/symbol/WTIU' title='ProShares Daily 3x Long Crude ETN'>WTIU</a>, <a href='https://seekingalpha.com/symbol/OILK' title='ProShares K-1 Free Crude Oil Strategy ETF'>OILK</a>, <a href='https://seekingalpha.com/symbol/OILX' title='Etracs S&P GSCI Crude Oil Total Return Index ETN'>OILX</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3470912\" data-linked=\"U.S. oil finishes 4% lower on crude build, demand fears\" data-tweet=\"$XLE $ROAN $SPN - U.S. oil finishes 4% lower on crude build, demand fears https://seekingalpha.com/news/3470912-u-s-oil-finishes-4-lower-on-crude-build-demand-fears?source=tweet\" data-url=\"https://seekingalpha.com/news/3470912-u-s-oil-finishes-4-lower-on-crude-build-demand-fears\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>86&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470910\" data-ts=\"1560370752\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RH\" target=\"_blank\">RH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470910-rhplus-20-after-earnings-topper\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RH +20% after earnings topper</a></h4><ul> <li>RH (NYSE:<a href='https://seekingalpha.com/symbol/RH' title='RH'>RH</a>) gains after <a href=\"https://seekingalpha.com/pr/17543014-rh-reports-record-first-quarter-fiscal-2019-results\" target=\"_blank\">Q1</a> results top some beaten-down expectations and the company guides for FY20 EPS of $8.76 to $9.27 vs. $8.32 consensus.</li> <li>RH says it's becoming one of the few retailers that is growing revenues, expanding margins, increasing operating earnings, and driving significantly higher returns on invested capital. Long-term targets from RH include net revenue growth of 8% to 12%, adjusted operating margins in the mid to high teens, adjusted net income growth of 15% to 20% annually and return on invested capital in excess of 50%.</li> <li>RH is up <font color=\"green\">+20.4%</font> AH after shares fell over 50% since the retailer's last earnings report.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3470910\" data-linked=\"RH +20% after earnings topper\" data-tweet=\"$RH - RH +20% after earnings topper https://seekingalpha.com/news/3470910-rhplus-20-after-earnings-topper?source=tweet\" data-url=\"https://seekingalpha.com/news/3470910-rhplus-20-after-earnings-topper\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470900\" data-ts=\"1560370428\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OXM\" target=\"_blank\">OXM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470900-oxford-industriesplus-6-after-profit-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oxford Industries +6% after profit beat</a></h4><ul> <li>Oxford Industries (NYSE:<a href='https://seekingalpha.com/symbol/OXM' title='Oxford Industries, Inc.'>OXM</a>) is on watch after <a href=\"https://seekingalpha.com/pr/17543002-oxford-owner-tommy-bahama-lilly-pulitzer-southern-tide-reports-first-quarter-fiscal-2019\" target=\"_blank\">Q1</a> EPS arrived ahead of even the highest estimate turned in by analysts.</li> <li>\"Our first quarter performance reflects the strong positioning of Tommy Bahama, Lilly Pulitzer, and Southern Tide in the marketplace coupled with positive consumer response to our current merchandise assortments,' notes Oxford CEO Thomas Chubb III.</li> <li>Comparable sales were up 2% the quarter.</li> <li>Gross profit fell to 58.8% of sales from 60.2% a year ago on a higher proportion of sales from the company's lower margin Lanier Apparel business and lower gross margin at Lilly Pulitzer.</li> <li>Operating income was $30.0M vs. $29.4 a year ago.</li> <li>Looking ahead, Oxford expects Q2 sales of $300M to $310M vs. $313M and EPS $1.80 to $1.90 vs. $1.93 consensus.</li> <li>Shares of Oxford are <font color=\"green\">up 6.17%</font> AH to $73.15.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3470896-oxford-industries-eps-beats-0_09-beats-revenue\" target=\"_blank\">Oxford Industries EPS beats by $0.09, beats on revenue</a> (June 12)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3470900\" data-linked=\"Oxford Industries +6% after profit beat\" data-tweet=\"$OXM - Oxford Industries +6% after profit beat https://seekingalpha.com/news/3470900-oxford-industriesplus-6-after-profit-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3470900-oxford-industriesplus-6-after-profit-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:13 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470899\" data-ts=\"1560370400\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RH\" target=\"_blank\">RH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470899-rh-eps-beats-0_32-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RH EPS beats by $0.32, beats on revenue</a></h4><ul><li>RH (NYSE:<a href='https://seekingalpha.com/symbol/RH' title='RH'>RH</a>): Q1 Non-GAAP EPS of $1.85 <font color=\"green\">beats by $0.32</font>; GAAP EPS of $1.43 <font color=\"red\">misses by $0.03</font>.</li><li>Revenue of $598.42M (+7.4% Y/Y) <font color=\"green\">beats by $14.73M</font>.</li><li>Shares <font color=\"green\">+21.2%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17543014-rh-reports-record-first-quarter-fiscal-2019-results\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3470899\" data-linked=\"RH EPS beats by $0.32, beats on revenue\" data-tweet=\"$RH - RH EPS beats by $0.32, beats on revenue https://seekingalpha.com/news/3470899-rh-eps-beats-0_32-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3470899-rh-eps-beats-0_32-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470896\" data-ts=\"1560370057\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OXM\" target=\"_blank\">OXM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470896-oxford-industries-eps-beats-0_09-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oxford Industries EPS beats by $0.09, beats on revenue</a></h4><ul><li>Oxford Industries (NYSE:<a href='https://seekingalpha.com/symbol/OXM' title='Oxford Industries, Inc.'>OXM</a>): Q1 Non-GAAP EPS of $1.30 <font color=\"green\">beats by $0.09</font>; GAAP EPS of $1.29 <font color=\"green\">beats by $0.08</font>.</li><li>Revenue of $281.97M (+3.4% Y/Y) <font color=\"green\">beats by $5.22M</font>.</li><li>Shares <font color=\"green\">+1.74%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17543002-oxford-owner-tommy-bahama-lilly-pulitzer-southern-tide-reports-first-quarter-fiscal-2019\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3470896\" data-linked=\"Oxford Industries EPS beats by $0.09, beats on revenue\" data-tweet=\"$OXM - Oxford Industries EPS beats by $0.09, beats on revenue https://seekingalpha.com/news/3470896-oxford-industries-eps-beats-0_09-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3470896-oxford-industries-eps-beats-0_09-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:07 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470894\" data-ts=\"1560369997\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LULU\" target=\"_blank\">LULU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470894-lululemon-athletica-eps-beats-0_04-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lululemon Athletica EPS beats by $0.04, beats on revenue</a></h4><ul><li>Lululemon Athletica (NASDAQ:<a href='https://seekingalpha.com/symbol/LULU' title='Lululemon Athletica Inc.'>LULU</a>): Q1 GAAP EPS of $0.74 <font color=\"green\">beats by $0.04</font>.</li><li>Revenue of $782M (+20.4% Y/Y) <font color=\"green\">beats by $26.08M</font>.</li><li>Shares <font color=\"green\">+2.3%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17542996-lululemon-athletica-inc-announces-first-quarter-fiscal-2019-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3470894\" data-linked=\"Lululemon Athletica EPS beats by $0.04, beats on revenue\" data-tweet=\"$LULU - Lululemon Athletica EPS beats by $0.04, beats on revenue https://seekingalpha.com/news/3470894-lululemon-athletica-eps-beats-0_04-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3470894-lululemon-athletica-eps-beats-0_04-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470882\" data-ts=\"1560369818\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADYX\" target=\"_blank\">ADYX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470882-adynxx-down-38-on-nasdaq-delisting\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Adynxx down 38% on Nasdaq delisting</a></h4><ul><li>Thinly traded nano cap Adynxx (<a href='https://seekingalpha.com/symbol/ADYX' title='Adynxx, Inc.'>ADYX</a> <font color=\"red\">-38.2%</font>) is down on more than a 6x surge in volume, albeit on turnover of only 108K shares, in response to <a href=\"https://seekingalpha.com/pr/17542778-adynxx-stock-move-otc-market-following-receipt-nasdaq-delisting-notice\" target=\"_blank\">delisting </a>from Nasdaq effective today due to noncompliance with its listing requirements for minimum round lot stockholders and minimum stockholders' equity.</li><li>The company expects its stock to trade on the OTC Markets Pink tier effective tomorrow.</li></ul><div class=\"tiny-share-widget\" data-id=\"3470882\" data-linked=\"Adynxx down 38% on Nasdaq delisting\" data-tweet=\"$ADYX - Adynxx down 38% on Nasdaq delisting https://seekingalpha.com/news/3470882-adynxx-down-38-on-nasdaq-delisting?source=tweet\" data-url=\"https://seekingalpha.com/news/3470882-adynxx-down-38-on-nasdaq-delisting\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:03 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470889\" data-ts=\"1560369794\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470889-alphabet-benefits-from-crowdstrikes-strong-ipo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alphabet benefits from CrowdStrike&#39;s strong IPO</a></h4><ul><li>CrowdStrike (NASDAQ:<a href='https://seekingalpha.com/symbol/CRWD' title='CrowdStrike Holdings, Inc.'>CRWD</a>) closes its first day of trading <font color=\"green\">up 70.6%</font> to $58.</li><li>Alphabet (<a href='https://seekingalpha.com/symbol/GOOG' title='Alphabet Inc.'>GOOG</a>,<a href='https://seekingalpha.com/symbol/GOOGL' title='Alphabet Inc.'>GOOGL</a>) also won in the cybersecurity company's strong debut. The CapitalG investment group has a stake of about $1.2B, making it the third largest shareholder.</li></ul><div class=\"tiny-share-widget\" data-id=\"3470889\" data-linked=\"Alphabet benefits from CrowdStrike&#39;s strong IPO\" data-tweet=\"$CRWD $GOOG $GOOGL - Alphabet benefits from CrowdStrike&#39;s strong IPO https://seekingalpha.com/news/3470889-alphabet-benefits-from-crowdstrikes-strong-ipo?source=tweet\" data-url=\"https://seekingalpha.com/news/3470889-alphabet-benefits-from-crowdstrikes-strong-ipo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470866\" data-ts=\"1560369100\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JNJ\" target=\"_blank\">JNJ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470866-j-and-j-and-colgate-palmolive-on-short-end-of-talc-verdict\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">J&amp;J and Colgate-Palmolive on short end of talc verdict</a></h4><ul><li>Bloomberg reports that a California jury has ruled in favor of plaintiff Patricia Schmitz, agreeing with <a href=\"https://seekingalpha.com/news/3468352-talc-case-california-j-and-j-colgate-palmolive-winding\" target=\"_blank\">her claim</a> that talc products made by Johnson &amp; Johnson (<a href='https://seekingalpha.com/symbol/JNJ' title='Johnson & Johnson'>JNJ</a> <font color=\"green\">+1.3%</font>) and Colgate-Palmolive (<a href='https://seekingalpha.com/symbol/CL' title='Colgate-Palmolive Company'>CL</a> <font color=\"red\">-0.5%</font>) caused her cancer.</li><li><strong>Update</strong>: The jury ruled that the companies' products caused her mesothelioma and that each were 40% responsible (~$4.8M in damages each). Avon Products (<a href='https://seekingalpha.com/symbol/AVP' title='Avon Products, Inc.'>AVP</a> <font color=\"red\">-2.6%</font>) was deemed 20% responsible (~$2.4M). The jury rejected her claim for punitive damages. JNJ intends to appeal.</li></ul><div class=\"tiny-share-widget\" data-id=\"3470866\" data-linked=\"J&amp;J and Colgate-Palmolive on short end of talc verdict\" data-tweet=\"$JNJ $CL $AVP - J&amp;J and Colgate-Palmolive on short end of talc verdict https://seekingalpha.com/news/3470866-j-and-j-and-colgate-palmolive-on-short-end-of-talc-verdict?source=tweet\" data-url=\"https://seekingalpha.com/news/3470866-j-and-j-and-colgate-palmolive-on-short-end-of-talc-verdict\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:51 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>37&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470874\" data-ts=\"1560366638\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPOT\" target=\"_blank\">SPOT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470874-rosenblatt-praises-spotify-price-power-looks-to-margin-clarity\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rosenblatt praises Spotify price power, looks to margin clarity</a></h4><ul>   <li>Rosenblatt Securities reiterated its Buy rating on Spotify (<a href=\"http://seekingalpha.com/symbol/SPOT\" target=\"_blank\">SPOT</a> <font color=\"green\">+2.4%</font>), pointing to growing pricing leverage in American and looking to more clarity on gross margins at earnings time.</li>    <li>The music streamer will probably resume subscriptions to a bundle of Hulu and Spotify Premium before year-end, which will offer expansion of a higher-priced tier of users, Rosenblatt says.</li>    <li>The firm has a $175 price target, now implying 23% upside.</li>    <li>Sell-siders rate Spotify an <a href=\"https://seekingalpha.com/symbol/SPOT/ratings/sell-side-ratings\" target=\"_blank\">Outperform on average</a> and Seeking Alpha authors are <a href=\"https://seekingalpha.com/symbol/SPOT/ratings/author-ratings#filter=all\" target=\"_blank\">Bullish overall</a>, while its <a href=\"https://seekingalpha.com/symbol/SPOT/ratings/quant-ratings\" target=\"_blank\">Quant rating</a> is at Neutral.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3470874\" data-linked=\"Rosenblatt praises Spotify price power, looks to margin clarity\" data-tweet=\"$SPOT - Rosenblatt praises Spotify price power, looks to margin clarity https://seekingalpha.com/news/3470874-rosenblatt-praises-spotify-price-power-looks-to-margin-clarity?source=tweet\" data-url=\"https://seekingalpha.com/news/3470874-rosenblatt-praises-spotify-price-power-looks-to-margin-clarity\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470871\" data-ts=\"1560365916\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470871-ayx-pd-and-mx-among-notable-tech-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AYX, PD and MX among notable tech movers</a></h4><ul><li><strong>Gainers:</strong> B Communications (NASDAQ:<a href='https://seekingalpha.com/symbol/BCOM' title='B Communications Ltd'>BCOM</a>) <font color=\"green\">+30%</font>. MagnaChip Semiconductor (NYSE:<a href='https://seekingalpha.com/symbol/MX' title='MagnaChip Semiconductor Corporation'>MX</a>) <font color=\"green\">+12%</font>. PagerDuty (NYSE:<a href='https://seekingalpha.com/symbol/PD' title='PagerDuty, Inc.'>PD</a>) <font color=\"green\">+10%</font>. Alteryx (NYSE:<a href='https://seekingalpha.com/symbol/AYX' title='Alteryx, Inc.'>AYX</a>) <font color=\"green\">+10%</font>. Orion Energy Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/OESX' title='Orion Energy Systems, Inc'>OESX</a>) <font color=\"green\">+10%</font>.</li> <li><strong>Losers: </strong>Intellicheck (NYSEMKT:<a href='https://seekingalpha.com/symbol/IDN' title='Intellicheck, Inc.'>IDN</a>) <font color=\"red\">-12%</font>. Frontier Communications (NASDAQ:<a href='https://seekingalpha.com/symbol/FTR' title='Frontier Communications Corporation'>FTR</a>) <font color=\"red\">-12%</font>. Safe-T Group (NASDAQ:<a href='https://seekingalpha.com/symbol/SFET' title='Safe-T Group Ltd'>SFET</a>) <font color=\"red\">-9%</font>. SciPlay (NASDAQ:<a href='https://seekingalpha.com/symbol/SCPL' title='SciPlay Corporation'>SCPL</a>) <font color=\"red\">-9%</font>. Pintec Technology Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/PT' title='Pintec Technology Holdings Limited'>PT</a>) <font color=\"red\">-8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3470871\" data-linked=\"AYX, PD and MX among notable tech movers\" data-tweet=\"$BCOM $MX $PD - AYX, PD and MX among notable tech movers https://seekingalpha.com/news/3470871-ayx-pd-and-mx-among-notable-tech-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3470871-ayx-pd-and-mx-among-notable-tech-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470861\" data-ts=\"1560362517\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470861-overall-energy-sector-lags-crude-oil-prices-moved-lower-following-eia-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Overall Energy sector lags as crude oil prices moved lower following EIA data</a></h4><ul><li><b>Gainers: </b>Golden Star Resources (NYSEMKT:<a href='https://seekingalpha.com/symbol/GSS' title='Golden Star Resources Ltd.'>GSS</a>) <font color=\"green\">+6%</font>. Flexible Solutions International (NYSEMKT:<a href='https://seekingalpha.com/symbol/FSI' title='Flexible Solutions International Inc.'>FSI</a>) <font color=\"green\">+6%</font>. McEwen Mining (NYSE:<a href='https://seekingalpha.com/symbol/MUX' title='McEwen Mining Inc.'>MUX</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers: </b>Basic Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/BAS' title='Basic Energy Services, Inc.'>BAS</a>) <font color=\"red\">-16%</font>. Roan Resources (NYSE:<a href='https://seekingalpha.com/symbol/ROAN' title='Roan Resources, Inc.'>ROAN</a>) <font color=\"red\">-15%</font>. Superior Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/SPN' title='Superior Energy Services, Inc.'>SPN</a>) <font color=\"red\">-13%</font>. Noble Corporation (NYSE:<a href='https://seekingalpha.com/symbol/NE' title='Noble Corporation plc'>NE</a>) <font color=\"red\">-11%</font>. Obsidian Energy (NYSE:<a href='https://seekingalpha.com/symbol/OBE' title='Obsidian Energy Ltd.'>OBE</a>) <font color=\"red\">-10%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3470861\" data-linked=\"Overall Energy sector lags as crude oil prices moved lower following EIA data\" data-tweet=\"$GSS $FSI $MUX - Overall Energy sector lags as crude oil prices moved lower following EIA data https://seekingalpha.com/news/3470861-overall-energy-sector-lags-crude-oil-prices-moved-lower-following-eia-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3470861-overall-energy-sector-lags-crude-oil-prices-moved-lower-following-eia-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470859\" data-ts=\"1560362352\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BB\" target=\"_blank\">BB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470859-peers-gain-on-crowdstrikes-strong-debut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Peers gain on CrowdStrike&#39;s strong debut</a></h4><ul><li>CrowdStrike peers Carbon Black (<a href='https://seekingalpha.com/symbol/CBLK' title='Carbon Black, Inc.'>CBLK</a> <font color='green'>+2.6%</font>) and BlackBerry's (<a href='https://seekingalpha.com/symbol/BB' title='BlackBerry Limited'>BB</a> <font color='green'>+6.9%</font>) Cylance are among the cybersecurity names moving after its <a href=\"https://seekingalpha.com/symbol/CRWD?s=crwd\" target=\"_blank\">strong public debut</a>.</li><li>Related security ETFs: <a href='https://seekingalpha.com/symbol/HACK' title='PureFunds ISE Cyber Security ETF'>HACK</a>, <a href='https://seekingalpha.com/symbol/CIBR' title='First Trust Nasdaq CEA Cybersecurity ETF'>CIBR</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3470859\" data-linked=\"Peers gain on CrowdStrike&#39;s strong debut\" data-tweet=\"$BB $CBLK $CBLK - Peers gain on CrowdStrike&#39;s strong debut https://seekingalpha.com/news/3470859-peers-gain-on-crowdstrikes-strong-debut?source=tweet\" data-url=\"https://seekingalpha.com/news/3470859-peers-gain-on-crowdstrikes-strong-debut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>34&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470853\" data-ts=\"1560361153\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTIP\" target=\"_blank\">NTIP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470853-networkminus-1-increases-share-repurchase-program\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Network-1 increases its share repurchase program</a></h4><ul><li>Network-1 Technologies (<a href='https://seekingalpha.com/symbol/NTIP' title='Network-1 Technologies, Inc.'>NTIP</a> <font color='green'>+3.4%</font>) has <a href=\"https://seekingalpha.com/pr/17542811-networkminus-1-increases-share-repurchase-program\" target=\"_blank\">extended and increased</a> its previously announced share repurchase program.</li><li>The Company to repurchase up to $5,000,000 of shares of its common stock over the next two years (for a total authorization since inception of the program of ~$22,000,000).</li><li>Corey M. Horowitz, Chairman and CEO of Network-1. \"This, our sixth increase of our Share Repurchase Program, reflects our confidence in the long-term potential for Network-1 and our commitment to increasing shareholder value\".</li></ul><div class=\"tiny-share-widget\" data-id=\"3470853\" data-linked=\"Network-1 increases its share repurchase program\" data-tweet=\"$NTIP - Network-1 increases its share repurchase program https://seekingalpha.com/news/3470853-networkminus-1-increases-share-repurchase-program?source=tweet\" data-url=\"https://seekingalpha.com/news/3470853-networkminus-1-increases-share-repurchase-program\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:39 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470961\" data-ts=\"1560359564\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RBGLY\" target=\"_blank\">RBGLY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470961-reckitt-names-pepsico-exec-narasimhan-new-ceo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reckitt names PepsiCo exec Narasimhan as new CEO</a></h4><ul><li>Reckitt Benckiser (<a href='https://seekingalpha.com/symbol/RBGLY' title='Reckitt Benckiser Group plc'>OTCPK:RBGLY</a> <font color='green'>+4.6%</font>) names PepsiCo (<a href='https://seekingalpha.com/symbol/PEP' title='PepsiCo, Inc.'>PEP</a>) executive Laxman Narasimhan as its <a href=\"https://www.reuters.com/article/us-reckitt-benc-grp-ceo/reckitt-picks-pepsico-exec-as-ceo-going-outside-for-first-time-idUSKCN1TD0IS\" target=\"_blank\">next CEO</a>, marking the first external candidate to be appointed to run the company since it was formed in 1999.</li><li>Narasimhan, PEP's global chief commercial officer, takes over as CEO on Sept. 1, replacing Rakesh Kapoor, who has led Reckitt for more than eight years and said in January he planned to retire.</li><li>Most analysts appear to welcome the selection, saying the new CEO would inject a fresh perspective to a company facing industry-wide challenges to growth.</li></ul><div class=\"tiny-share-widget\" data-id=\"3470961\" data-linked=\"Reckitt names PepsiCo exec Narasimhan as new CEO\" data-tweet=\"$RBGLY $RBGLY $PEP - Reckitt names PepsiCo exec Narasimhan as new CEO https://seekingalpha.com/news/3470961-reckitt-names-pepsico-exec-narasimhan-new-ceo?source=tweet\" data-url=\"https://seekingalpha.com/news/3470961-reckitt-names-pepsico-exec-narasimhan-new-ceo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470850\" data-ts=\"1560359418\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470850-banco-macro-leads-financial-gainers-ppdai-group-and-realogy-holdings-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Banco Macro leads financial gainers, PPDAI Group and Realogy Holdings among losers</a></h4><ul><li><b>Gainers:</b> Banco Macro (NYSE:<a href='https://seekingalpha.com/symbol/BMA' title='Banco Macro S.A.'>BMA</a>) <font color=\"green\">+10%</font>. Grupo Financiero Galicia (NASDAQ:<a href='https://seekingalpha.com/symbol/GGAL' title='Grupo Financiero Galicia S.A.'>GGAL</a>) <font color=\"green\">+9%</font>. IRSA Inversiones y Representaciones (NYSE:<a href='https://seekingalpha.com/symbol/IRS' title='IRSA Inversiones y Representaciones Sociedad Anónima'>IRS</a>) <font color=\"green\">+7%</font>. Mmtec (NASDAQ:<a href='https://seekingalpha.com/symbol/MTC' title='Mmtec, Inc.'>MTC</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers:</b> PPDAI Group (NYSE:<a href='https://seekingalpha.com/symbol/PPDF' title='PPDAI Group Inc.'>PPDF</a>) <font color=\"red\">-9%</font>. MoneyGram International (NASDAQ:<a href='https://seekingalpha.com/symbol/MGI' title='MoneyGram International, Inc.'>MGI</a>) <font color=\"red\">-7%</font>. Yintech Investment Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/YIN' title='Yintech Investment Holdings Limited'>YIN</a>) <font color=\"red\">-6%</font>. Realogy Holdings (NYSE:<a href='https://seekingalpha.com/symbol/RLGY' title='Realogy Holdings Corp.'>RLGY</a>) <font color=\"red\">-5%</font>. Oxbridge Re Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/OXBR' title='Oxbridge Re Holdings Limited'>OXBR</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3470850\" data-linked=\"Banco Macro leads financial gainers, PPDAI Group and Realogy Holdings among losers\" data-tweet=\"$BMA $GGAL $IRS - Banco Macro leads financial gainers, PPDAI Group and Realogy Holdings among losers https://seekingalpha.com/news/3470850-banco-macro-leads-financial-gainers-ppdai-group-and-realogy-holdings-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3470850-banco-macro-leads-financial-gainers-ppdai-group-and-realogy-holdings-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:10 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470848\" data-ts=\"1560359012\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470848-mayville-engineering-and-loma-negra-compania-among-industrial-gainers-ballard-power-systems\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mayville Engineering and Loma Negra Compania among industrial gainers; Ballard Power Systems and Summit Materials among losers</a></h4><ul><li><b>Gainers: </b>Mayville Engineering Company (NYSE:<a href='https://seekingalpha.com/symbol/MEC' title='Mayville Engineering Company, Inc.'>MEC</a>) <font color=\"green\">+8%</font>. Loma Negra Compania Industrial (NYSE:<a href='https://seekingalpha.com/symbol/LOMA' title='Loma Negra Compañía Industrial Argentina Sociedad Anónima'>LOMA</a>) <font color=\"green\">+7%</font>.</li><li><b>Losers: </b>Hebron Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/HEBT' title='Hebron Technology Co., Ltd.'>HEBT</a>) <font color=\"red\">-15%</font>. Concrete Pumping Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/BBCP' title='Industrea Acquisition Corp.'>BBCP</a>) <font color=\"red\">-7%</font>. Ballard Power Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/BLDP' title='Ballard Power Systems Inc.'>BLDP</a>) <font color=\"red\">-7%</font>. Summit Materials (NYSE:<a href='https://seekingalpha.com/symbol/SUM' title='Summit Materials, Inc.'>SUM</a>) <font color=\"red\">-6%</font>. Kornit Digital (NASDAQ:<a href='https://seekingalpha.com/symbol/KRNT' title='Kornit Digital Ltd.'>KRNT</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3470848\" data-linked=\"Mayville Engineering and Loma Negra Compania among industrial gainers; Ballard Power Systems and Summit Materials among losers\" data-tweet=\"$MEC $LOMA $HEBT - Mayville Engineering and Loma Negra Compania among industrial gainers; Ballard Power Systems and Summit Materials among losers https://seekingalpha.com/news/3470848-mayville-engineering-and-loma-negra-compania-among-industrial-gainers-ballard-power-systems?source=tweet\" data-url=\"https://seekingalpha.com/news/3470848-mayville-engineering-and-loma-negra-compania-among-industrial-gainers-ballard-power-systems\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:03 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470846\" data-ts=\"1560358429\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/D\" target=\"_blank\">D</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470846-dominion-foresees-victory-in-atlantic-coast-pipeline-legal-challenges\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dominion foresees victory in Atlantic Coast Pipeline legal challenges</a></h4><ul><li>Dominion Energy (<a href='https://seekingalpha.com/symbol/D' title='Dominion Energy, Inc.'>D</a> <font color='green'>+1.5%</font>) says it <a href=\"https://www.spglobal.com/platts/en/market-insights/latest-news/natural-gas/061119-dominion-confident-it-will-win-atlantic-coast-pipeline-legal-challenges\" target=\"_blank\">expects to win</a> one of two legal challenges faced by the Atlantic  Coast Pipeline within the next 4-6 weeks, which would allow it to resume construction on part of the $7.5B project.</li><li>Donald Raikes, senior VP for gas transmission operations in  Dominion's Gas Infrastructure Group, also believes the U.S. Supreme Court will agree to hear the second legal challenge, involving a  permit to cross the Appalachian Trail, and ultimately rule in the company's favor.</li><li>The optimism comes as Dominion holds to its current timeline to begin  partial service in late 2020 and full service in early 2021.</li><li>Separately, Dominion CEO Thomas Farrell says the Environmental Protection Agency's effort  to encourage efficiency upgrades at coal plants will not inspire them  to alter plans to transition to cleaner energy.</li><li>\"We are going to stay on our path,\" the CEO says, noting coal has fallen to 11% of total power produced by Dominion from 55%, helping the utility stay on track  for its goal of reducing emissions 50% by 2030 and 80% by 2050.</li></ul><div class=\"tiny-share-widget\" data-id=\"3470846\" data-linked=\"Dominion foresees victory in Atlantic Coast Pipeline legal challenges\" data-tweet=\"$D $DUK $SO - Dominion foresees victory in Atlantic Coast Pipeline legal challenges https://seekingalpha.com/news/3470846-dominion-foresees-victory-in-atlantic-coast-pipeline-legal-challenges?source=tweet\" data-url=\"https://seekingalpha.com/news/3470846-dominion-foresees-victory-in-atlantic-coast-pipeline-legal-challenges\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470836\" data-ts=\"1560357547\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470836-microcaps-dominate-midday-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Microcaps dominate midday movers</a></h4><ul><li><strong>Gainers: </strong>Synlogic (NASDAQ:<a href='https://seekingalpha.com/symbol/SYBX' title='Synlogic, Inc.'>SYBX</a>) <font color=\"green\">+28%</font>. Immuron (NASDAQ:<a href='https://seekingalpha.com/symbol/IMRN' title='Immuron Limited'>IMRN</a>) <font color=\"green\">+26%</font>. B Communications (NASDAQ:<a href='https://seekingalpha.com/symbol/BCOM' title='B Communications Ltd'>BCOM</a>) <font color=\"green\">+23%</font>. Arcadia Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/RKDA' title='Arcadia Biosciences, Inc.'>RKDA</a>) <font color=\"green\">+17%</font>. Vuzix Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/VUZI' title='Vuzix Corporation'>VUZI</a>) <font color=\"green\">+14%</font>. MagnaChip Semiconductor Corporation (NYSE:<a href='https://seekingalpha.com/symbol/MX' title='MagnaChip Semiconductor Corporation'>MX</a>) <font color=\"green\">+13%</font>. Osmotica Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/OSMT' title='Osmotica Pharmaceuticals plc'>OSMT</a>) <font color=\"green\">+12%</font>. Tocagen (NASDAQ:<a href='https://seekingalpha.com/symbol/TOCA' title='Tocagen Inc.'>TOCA</a>) <font color=\"green\">+12%</font>. Taitron Components (NASDAQ:<a href='https://seekingalpha.com/symbol/TAIT' title='Taitron Components Incorporated'>TAIT</a>) <font color=\"green\">+12%</font>. U.S. Auto Parts Network (NASDAQ:<a href='https://seekingalpha.com/symbol/PRTS' title='U.S. Auto Parts Network, Inc.'>PRTS</a>) <font color=\"green\">+12%</font>.</li> <li><strong>Losers: </strong>Dave &amp; Buster's Entertainment (NASDAQ:<a href='https://seekingalpha.com/symbol/PLAY' title='Dave & Buster&#39;s Entertainment, Inc.'>PLAY</a>) <font color=\"red\">-22%</font>. Hooker Furniture (NASDAQ:<a href='https://seekingalpha.com/symbol/HOFT' title='Hooker Furniture Corporation'>HOFT</a>) <font color=\"red\">-20%</font>. NovaBay Pharmaceuticals (NYSEMKT:<a href='https://seekingalpha.com/symbol/NBY' title='NovaBay Pharmaceuticals, Inc.'>NBY</a>) <font color=\"red\">-19%</font>. Estre Ambiental (NASDAQ:<a href='https://seekingalpha.com/symbol/ESTR' title='Estre Ambiental, Inc.'>ESTR</a>) <font color=\"red\">-18%</font>. Jaguar Health (NASDAQ:<a href='https://seekingalpha.com/symbol/JAGX' title='Jaguar Health, Inc.'>JAGX</a>) <font color=\"red\">-16%</font>. Hebron Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/HEBT' title='Hebron Technology Co., Ltd.'>HEBT</a>) <font color=\"red\">-15%</font>. ContraVir Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CTRV' title='ContraVir Pharmaceuticals, Inc.'>CTRV</a>) <font color=\"red\">-14%</font>. Novus Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/NVUS' title='Novus Therapeutics, Inc.'>NVUS</a>) <font color=\"red\">-13%</font>. Roan Resources (NYSE:<a href='https://seekingalpha.com/symbol/ROAN' title='Roan Resources, Inc.'>ROAN</a>) <font color=\"red\">-13%</font>. Navidea Biopharmaceuticals (NYSEMKT:<a href='https://seekingalpha.com/symbol/NAVB' title='Navidea Biopharmaceuticals, Inc.'>NAVB</a>) <font color=\"red\">-12%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3470836\" data-linked=\"Microcaps dominate midday movers\" data-tweet=\"$SYBX $IMRN $BCOM - Microcaps dominate midday movers https://seekingalpha.com/news/3470836-microcaps-dominate-midday-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3470836-microcaps-dominate-midday-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470831\" data-ts=\"1560357438\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RKDA\" target=\"_blank\">RKDA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470831-ag-bio-players-rally-on-trump-order-for-simpler-path-for-bioengineered-crops\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ag bio players rally on Trump order for simpler path for bioengineered crops</a></h4><ul><li>Agricultural biotechs Arcadia Biosciences (<a href='https://seekingalpha.com/symbol/RKDA' title='Arcadia Biosciences, Inc.'>RKDA</a> <font color=\"green\">+15.9%</font>) and Yield10 Bioscience (<a href='https://seekingalpha.com/symbol/YTEN' title='Yield10 Bioscience, Inc.'>YTEN</a> <font color=\"green\">+5.4%</font>) are both up on increased volume in apparent response to an <a href=\"https://www.bloomberg.com/news/articles/2019-06-11/trump-plans-to-sign-order-to-ease-approval-of-new-gmo-crops\" target=\"_blank\">executive order</a> from President Trump to federal agencies to ease the rules for approving genetically modified crops and other agricultural biotechnology.</li><li>The U.S. Department of Agriculture, the FDA and the EPA all have jurisdiction over genetically engineered agricultural products.</li><li><strong>Update</strong>: Investors appear to be overlooking compatriot Calyxt (<a href='https://seekingalpha.com/symbol/CLXT' title='Calyxt, Inc.'>CLXT</a> <font color=\"red\">-0.4%</font>).</li></ul><div class=\"tiny-share-widget\" data-id=\"3470831\" data-linked=\"Ag bio players rally on Trump order for simpler path for bioengineered crops\" data-tweet=\"$RKDA $YTEN $CLXT - Ag bio players rally on Trump order for simpler path for bioengineered crops https://seekingalpha.com/news/3470831-ag-bio-players-rally-on-trump-order-for-simpler-path-for-bioengineered-crops?source=tweet\" data-url=\"https://seekingalpha.com/news/3470831-ag-bio-players-rally-on-trump-order-for-simpler-path-for-bioengineered-crops\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470835\" data-ts=\"1560357194\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FCEL\" target=\"_blank\">FCEL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470835-fuelcell-energy-soars-on-exxon-license-agreement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FuelCell Energy soars on Exxon license agreement</a></h4><ul><li>FuelCell Energy (<a href='https://seekingalpha.com/symbol/FCEL' title='FuelCell Energy, Inc.'>FCEL</a> <font color='green'>+54.7%</font>) explodes higher after disclosing a <a href=\"https://www.sec.gov/Archives/edgar/data/886128/000114420419030657/tv523415_8k.htm\" target=\"_blank\">new license agreement</a> with Exxon Mobil (<a href='https://seekingalpha.com/symbol/XOM' title='Exxon Mobil Corporation'>XOM</a> <font color='red'>-0.7%</font>); trading has resumed after a brief halt.</li><li>FCEL says the deal grants XOM a non-exclusive and worldwide license to use its \"patents, data, know-how, improvements, equipment designs, methods, processes... to research, develop and commercially exploit carbonate fuel cells in applications in which the fuel cells concentrate carbon dioxide from industrial and power sources.\"</li><li>XOM will pay $10M to FCEL to become fully vested in the rights and licenses granted.</li></ul><div class=\"tiny-share-widget\" data-id=\"3470835\" data-linked=\"FuelCell Energy soars on Exxon license agreement\" data-tweet=\"$FCEL $XOM - FuelCell Energy soars on Exxon license agreement https://seekingalpha.com/news/3470835-fuelcell-energy-soars-on-exxon-license-agreement?source=tweet\" data-url=\"https://seekingalpha.com/news/3470835-fuelcell-energy-soars-on-exxon-license-agreement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:33 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>96&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470833\" data-ts=\"1560356884\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470833-semis-slide-evercore-sees-2020-recovery\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Semis slide as Evercore sees 2020 recovery</a></h4><ul><li>The Philadelphia Semiconductor Index <font color=\"red\">drops 1.9% </font>after this morning's Evercore note saying the memory recovery might not happen until H2 2020, which came with a Lam Research downgrade.</li><li>Evercore sees the most near-term risk for Lam, Micron (<a href='https://seekingalpha.com/symbol/MU' title='Micron Technology, Inc.'>MU</a> <font color=\"red\">-5.1%</font>), and Western Digital (<a href='https://seekingalpha.com/symbol/WDC' title='Western Digital Corporation'>WDC</a> <font color=\"red\">-4.7%</font>) (Underperform, $30 PT) from the continuing excess inventories in DRAM and NAND.</li><li>The analysts say they prefer ASML (<a href='https://seekingalpha.com/symbol/ASML' title='ASML Holding N.V.'>ASML</a> <font color=\"red\">-1.2%</font>) and Applied Materials (<a href='https://seekingalpha.com/symbol/AMAT' title='Applied Materials, Inc.'>AMAT</a> <font color=\"red\">-4.9%</font>) but cut AMAT's target from $55 to $50 while maintaining an Outperform rating.</li><li>More target cuts: KLA (<a href='https://seekingalpha.com/symbol/KLAC' title='KLA Corporation'>KLAC</a> <font color=\"red\">-2.9%</font>) from $130 to $120 and Teradyne (<a href='https://seekingalpha.com/symbol/TER' title='Teradyne, Inc.'>TER</a> <font color=\"red\">-3.3%</font>) from $47 to $43.</li><li>Related semi ETFs: <a href='https://seekingalpha.com/symbol/SOXL' title='Direxion Daily Semiconductor 3x Bull Shares ETF'>SOXL</a>, <a href='https://seekingalpha.com/symbol/SOXX' title='iShares PHLX SOX Semiconductor Sector Index ETF'>SOXX</a>, <a href='https://seekingalpha.com/symbol/SMH' title='VanEck Vectors Semiconductor ETF'>SMH</a>, <a href='https://seekingalpha.com/symbol/USD' title='ProShares Ultra Semiconductors ETF'>USD</a>, <a href='https://seekingalpha.com/symbol/PSI' title='Invesco Exchange-Traded Fund Trust - Invesco Dynamic Semiconductors ETF'>PSI</a>, <a href='https://seekingalpha.com/symbol/XSD' title='SPDR S&P Semiconductor ETF'>XSD</a>, <a href='https://seekingalpha.com/symbol/SOXS' title='Direxion Daily Semiconductor 3x Bear Shares ETF'>SOXS</a>, <a href='https://seekingalpha.com/symbol/SSG' title='ProShares UltraShort Semiconductors ETF'>SSG</a>, <a href='https://seekingalpha.com/symbol/FTXL' title='First Trust Exchange-Traded Fund VI - First Trust Nasdaq Semiconductor ETF'>FTXL</a>, <a href='https://seekingalpha.com/symbol/XTH' title='SPDR S&P Technology Hardware ETF'>XTH</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3470833\" data-linked=\"Semis slide as Evercore sees 2020 recovery\" data-tweet=\"$MU $WDC $ASML - Semis slide as Evercore sees 2020 recovery https://seekingalpha.com/news/3470833-semis-slide-evercore-sees-2020-recovery?source=tweet\" data-url=\"https://seekingalpha.com/news/3470833-semis-slide-evercore-sees-2020-recovery\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>87&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470832\" data-ts=\"1560356776\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470832-thestreet-sale-closes-door-on-strategic-review-sell-offs\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TheStreet sale closes door on strategic review, sell-offs</a></h4><ul>   <li>TheStreet's (<a href=\"http://seekingalpha.com/symbol/TST\" target=\"_blank\">TST</a> <font color=\"green\">+6.5%</font>) <a href=\"https://seekingalpha.com/news/3470724-thestreet-agrees-sale\" target=\"_blank\">$16.5M sale to TheMaven</a> (<a href=\"http://seekingalpha.com/symbol/MVEN\" target=\"_blank\">MVEN</a> <font color=\"green\">+0.3%</font>) wraps up the end of a yearlong strategic review that had already seen the company shed its business-to-business operation, which was generating about half the company's revenues.</li><li>It likely means a transformation of the most visible part of the company, including a probable exit of Jim Cramer.</li><li>The company once had a market cap of $1.7B after going public in 1999, but has of late struggled to maintain profits.</li>    <li>TheStreet sold RateWatch in June 2018 (to S&amp;P Global for $28.2M), and this year closed on sales of TheDeal and BoardEx to Euromoney for about $87.3M. CEO David Callaway exited with the latter deal, with CFO Eric Lundberg stepping up to the chief executive job.</li>    <li>That also resulted in a <a href=\"https://seekingalpha.com/news/3448239-thestreet-plus-5_2-percent-cash-distribution-1minus-10-reverse-split\" target=\"_blank\">cash distribution to shareholders</a> of about $94.3M (about $1.77/share at the time); the company executed a 1-for-10 reverse split in late April, leaving 5.3M shares outstanding.</li>    <li>Before those deals, the company then known as Tronc considered a buyout when TheStreet's market cap was just under $70M.</li>    <li>And it's doubtful that TheStreet's biggest public face, co-founder Jim Cramer, will remain with the company. This week he terminated his employment agreement, and so has 30 days to exit or set a new agreement.</li>    <li>Now TheMaven -- used by small and mid-sized brands as a digital platform -- talks about how its new acquisition could be the core of a <a href=\"https://nypost.com/2019/06/12/jim-cramers-financial-news-company-the-street-has-agreed-to-sell/\" target=\"_blank\">new financial vertical</a>, with a \"powerful and important voice delivering market-leading financial insights.\u201d</li> </ul><div class=\"tiny-share-widget\" data-id=\"3470832\" data-linked=\"TheStreet sale closes door on strategic review, sell-offs\" data-tweet=\"$TST $MVEN - TheStreet sale closes door on strategic review, sell-offs https://seekingalpha.com/news/3470832-thestreet-sale-closes-door-on-strategic-review-sell-offs?source=tweet\" data-url=\"https://seekingalpha.com/news/3470832-thestreet-sale-closes-door-on-strategic-review-sell-offs\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470826\" data-ts=\"1560355965\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FB\" target=\"_blank\">FB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470826-facebookminus-2-amid-report-emails-connect-ceo-to-questionable-privacy-approach\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Facebook -2% amid report emails connect CEO to questionable privacy approach</a></h4><ul>   <li>Facebook (NASDAQ:<a href='https://seekingalpha.com/symbol/FB' title='Facebook, Inc.'>FB</a>) has uncovered emails that seem to connect CEO Mark Zuckerberg to <a href=\"https://www.wsj.com/articles/facebook-worries-emails-could-show-zuckerberg-knew-of-questionable-privacy-practices-11560353829?mod=e2tw\" target=\"_blank\">knowledge of questionable privacy practices</a>, <i>The Wall Street Journal</i> reports.</li>    <li>That could present a new public-relations snafu (at least) for a company that's endured a string of them in the past few years. Shares have legged down and are now <font color=\"red\">-2%</font> on the day.</li>    <li>Sources tell the <i>WSJ</i> that the potential impact of the mails has pushed the company toward a quick settlement of its FTC investigation. The mails sent around the time of a 2012 FTC consent decree suggest that Zuckerberg and fellow senior execs didn't make complying with the decree a priority.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3470826\" data-linked=\"Facebook -2% amid report emails connect CEO to questionable privacy approach\" data-tweet=\"$FB - Facebook -2% amid report emails connect CEO to questionable privacy approach https://seekingalpha.com/news/3470826-facebookminus-2-amid-report-emails-connect-ceo-to-questionable-privacy-approach?source=tweet\" data-url=\"https://seekingalpha.com/news/3470826-facebookminus-2-amid-report-emails-connect-ceo-to-questionable-privacy-approach\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>90&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470824\" data-ts=\"1560355343\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470824-vuzix-and-mattel-among-consumer-gainers-hooker-furniture-and-davidstea-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vuzix and Mattel among consumer gainers; Hooker Furniture and DAVIDsTEA among losers</a></h4><ul><li><b>Gainers: </b>Beyond Meat (NASDAQ:<a href='https://seekingalpha.com/symbol/BYND' title='Beyond Meat, Inc.'>BYND</a>) <font color=\"green\">+9%</font>. Vuzix (NASDAQ:<a href='https://seekingalpha.com/symbol/VUZI' title='Vuzix Corporation'>VUZI</a>) <font color=\"green\">+9%</font>. Tandy Leather Factory (NASDAQ:<a href='https://seekingalpha.com/symbol/TLF' title='Tandy Leather Factory, Inc.'>TLF</a>) <font color=\"green\">+7%</font>. Mattel (NASDAQ:<a href='https://seekingalpha.com/symbol/MAT' title='Mattel, Inc.'>MAT</a>) <font color=\"green\">+6%</font>. Cresud (NASDAQ:<a href='https://seekingalpha.com/symbol/CRESY' title='Cresud Sociedad Anónima Comercial, Inmobiliaria, Financiera y Agropecuaria'>CRESY</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers: </b>Hooker Furniture (NASDAQ:<a href='https://seekingalpha.com/symbol/HOFT' title='Hooker Furniture Corporation'>HOFT</a>) <font color=\"red\">-20%</font>. The Lovesac Company (NASDAQ:<a href='https://seekingalpha.com/symbol/LOVE' title='The Lovesac Company'>LOVE</a>) <font color=\"red\">-8%</font>. Acme United (NYSEMKT:<a href='https://seekingalpha.com/symbol/ACU' title='Acme United Corporation'>ACU</a>) <font color=\"red\">-8%</font>. DAVIDsTEA (NASDAQ:<a href='https://seekingalpha.com/symbol/DTEA' title='DAVIDsTEA Inc.'>DTEA</a>) <font color=\"red\">-8%</font>. Fuling Global (NASDAQ:<a href='https://seekingalpha.com/symbol/FORK' title='Fuling Global Inc.'>FORK</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3470824\" data-linked=\"Vuzix and Mattel among consumer gainers; Hooker Furniture and DAVIDsTEA among losers\" data-tweet=\"$BYND $VUZI $TLF - Vuzix and Mattel among consumer gainers; Hooker Furniture and DAVIDsTEA among losers https://seekingalpha.com/news/3470824-vuzix-and-mattel-among-consumer-gainers-hooker-furniture-and-davidstea-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3470824-vuzix-and-mattel-among-consumer-gainers-hooker-furniture-and-davidstea-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470820\" data-ts=\"1560354893\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AYX\" target=\"_blank\">AYX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470820-needham-boosts-alteryx-after-investor-event\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Needham boosts Alteryx after investor event</a></h4><ul><li>Needham reiterates a Buy rating and raises its Alteryx (NYSE:<a href='https://seekingalpha.com/symbol/AYX' title='Alteryx, Inc.'>AYX</a>) target from $108 to $120 after yesterday's investor event.</li><li>The firm cites AYX's <a href=\"https://seekingalpha.com/news/3470562-alteryx-sets-long-term-margin-targets\" target=\"_blank\">long-term margin targets</a>, \"extraordinarily positive\" customer conversations, and the introduction of three new functionality types meant to bridge analytic demands and the shortage of citizen data scientists.</li><li>Alteryx shares are <font color=\"green\">up 9.7%</font> to $105.11.</li></ul><div class=\"tiny-share-widget\" data-id=\"3470820\" data-linked=\"Needham boosts Alteryx after investor event\" data-tweet=\"$AYX - Needham boosts Alteryx after investor event https://seekingalpha.com/news/3470820-needham-boosts-alteryx-after-investor-event?source=tweet\" data-url=\"https://seekingalpha.com/news/3470820-needham-boosts-alteryx-after-investor-event\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470815\" data-ts=\"1560354095\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRWD\" target=\"_blank\">CRWD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470815-crowdstrikeplus-87-on-612m-ipo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CrowdStrike +87% on $612M IPO</a></h4><ul><li>CrowdStrike (NASDAQ:<a href='https://seekingalpha.com/symbol/CRWD' title='CrowdStrike Holdings, Inc.'>CRWD</a>) <font color=\"green\">pops 87%</font> to $63.50 on the open of its first trading day.</li><li>Shares <a href=\"https://seekingalpha.com/news/3470658-crowdstrike-prices-initial-public-offering\" target=\"_blank\">were priced</a> at $34, above the $28 to $30 range.</li><li>CrowdStrike raised $612M in the IPO.</li></ul><div class=\"tiny-share-widget\" data-id=\"3470815\" data-linked=\"CrowdStrike +87% on $612M IPO\" data-tweet=\"$CRWD - CrowdStrike +87% on $612M IPO https://seekingalpha.com/news/3470815-crowdstrikeplus-87-on-612m-ipo?source=tweet\" data-url=\"https://seekingalpha.com/news/3470815-crowdstrikeplus-87-on-612m-ipo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470814\" data-ts=\"1560353981\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ESV\" target=\"_blank\">ESV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470814-ensco-rowan-investor-urges-2_5b-special-dividend-payout\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ensco Rowan investor urges $2.5B special dividend payout</a></h4><ul><li>Ensco Rowan (<a href='https://seekingalpha.com/symbol/ESV' title='Ensco Rowan plc'>ESV</a> <font color=\"red\">-5.9%</font>) plunges to multi-year lows even as investor Luminus Management <a href=\"https://seekingalpha.com/pr/17542329-luminus-management-sends-proposal-enscorowan-plc-board-directors\" target=\"_blank\">proposes</a> the company launch a priority guaranteed bond offering to fund a $2.5B special dividend to shareholders.</li><li>Luminus, an investment advisor to funds and accounts that own a combined 4.5% stake in ESV, says it is \"extremely disappointed\" by the stock's performance both before and since the Ensco-Rowan merger.</li><li>Luminus thinks a near-term special dividend would precipitate a re-rating of ESV shares, \"helping to crystallize the company's       underappreciated fundamental value while allowing it to retain extensive       financial flexibility.\"</li><li>Drilling stocks are down across the board in today's trade: <a href='https://seekingalpha.com/symbol/NE' title='Noble Corporation plc'>NE</a> <font color=\"red\">-10.7%</font>, <a href='https://seekingalpha.com/symbol/DO' title='Diamond Offshore Drilling, Inc.'>DO</a> <font color=\"red\">-6.2%</font>, <a href='https://seekingalpha.com/symbol/SDLP' title='Seadrill Partners LLC'>SDLP</a> <font color=\"red\">-6.2%</font>, <a href='https://seekingalpha.com/symbol/SDRL' title='Seadrill Limited'>SDRL</a> <font color=\"red\">-5.8%</font>, <a href='https://seekingalpha.com/symbol/RIG' title='Transocean Ltd.'>RIG</a> <font color=\"red\">-5.3%</font>, <a href='https://seekingalpha.com/symbol/PDS' title='Precision Drilling Corporation'>PDS</a> <font color=\"red\">-4.1%</font>, <a href='https://seekingalpha.com/symbol/PTEN' title='Patterson-UTI Energy, Inc.'>PTEN</a> <font color=\"red\">-3.1%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3470814\" data-linked=\"Ensco Rowan investor urges $2.5B special dividend payout\" data-tweet=\"$ESV $NE $DO - Ensco Rowan investor urges $2.5B special dividend payout https://seekingalpha.com/news/3470814-ensco-rowan-investor-urges-2_5b-special-dividend-payout?source=tweet\" data-url=\"https://seekingalpha.com/news/3470814-ensco-rowan-investor-urges-2_5b-special-dividend-payout\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>118&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470812\" data-ts=\"1560353395\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470812-shipping-stocks-bid-down\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shipping stocks bid down</a></h4><ul> <li>The Baltic Dry Index is down for a third straight day, <font color=\"red\">peeling off 1.78%</font> to 1,105 points.</li> <li>The Capesize index is <font color=\"red\">down 3.05%</font> and the Panamax <font color=\"red\">1.46% lower</font>. Last year, the BDI was <a href=\"http://www.seatrade-maritime.com/news/europe/baltic-dry-index-can-no-longer-reflect-dry-bulk-shipping-performance-bimco.html\" target=\"_blank\">changed</a> from an equal-weight index for capesize, panamax, supramax and handysize to a weighting of 40% on capesize and 30% for panamax and supramax time charter averages.</li> <li>Beyond dry bulking names, shipping and tanker stocks in general are off on the day: Diana Shipping (<a href='https://seekingalpha.com/symbol/DSX' title='Diana Shipping Inc.'>DSX</a> <font color='red'>-0.7%</font>), DryShips (<a href='https://seekingalpha.com/symbol/DRYS' title='DryShips Inc.'>DRYS</a> <font color='red'>-1.1%</font>), Eagle Bulk Shipping (<a href='https://seekingalpha.com/symbol/EGLE' title='Eagle Bulk Shipping Inc.'>EGLE</a> <font color='red'>-2.3%</font>), Globus Maritime (<a href='https://seekingalpha.com/symbol/GLBS' title='Globus Maritime Limited'>GLBS</a> <font color='red'>-7.3%</font>), Navios Maritime (<a href='https://seekingalpha.com/symbol/NM' title='Navios Maritime Holdings Inc.'>NM</a> <font color='red'>-4.1%</font>), Navios Maritime Partners (<a href='https://seekingalpha.com/symbol/NMM' title='Navios Maritime Partners L.P.'>NMM</a> <font color='red'>-2%</font>), Safe Bulkers (<a href='https://seekingalpha.com/symbol/SB' title='Safe Bulkers, Inc.'>SB</a> <font color='red'>-1.4%</font>), Scorpio Bulkers (<a href='https://seekingalpha.com/symbol/SALT' title='Scorpio Bulkers Inc.'>SALT</a> <font color='red'>-5.4%</font>), Star Bulk Carriers (<a href='https://seekingalpha.com/symbol/SBLK' title='Star Bulk Carriers Corp.'>SBLK</a> <font color='red'>-3.1%</font>), Genco Shipping &amp; Trading (<a href='https://seekingalpha.com/symbol/GNK' title='Genco Shipping & Trading Limited'>GNK</a> <font color='red'>-3.5%</font>), Frontline (<a href='https://seekingalpha.com/symbol/FRO' title='Frontline Ltd.'>FRO</a> <font color='red'>-6.1%</font>), DHT Holdings (<a href='https://seekingalpha.com/symbol/DHT' title='DHT Holdings, Inc.'>DHT</a> <font color='red'>-2.5%</font>), Golden Ocean Group (<a href='https://seekingalpha.com/symbol/GOGL' title='Golden Ocean Group Limited'>GOGL</a> <font color='red'>-5%</font>), Seanergy Maritime Holdings (<a href='https://seekingalpha.com/symbol/SHIP' title='Seanergy Maritime Holdings Corp.'>SHIP</a> <font color='red'>-7.5%</font>), Scorpio Tankers (<a href='https://seekingalpha.com/symbol/STNG' title='Scorpio Tankers Inc.'>STNG</a> <font color='red'>-4.9%</font>) and Euronav (<a href='https://seekingalpha.com/symbol/EURN' title='Euronav NV'>EURN</a> <font color='red'>-2.8%</font>).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3470812\" data-linked=\"Shipping stocks bid down\" data-tweet=\"$DSX $DRYS $EGLE - Shipping stocks bid down https://seekingalpha.com/news/3470812-shipping-stocks-bid-down?source=tweet\" data-url=\"https://seekingalpha.com/news/3470812-shipping-stocks-bid-down\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470811\" data-ts=\"1560353294\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FMCC\" target=\"_blank\">FMCC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470811-fhfa-wants-new-competitors-for-frannie-cowen\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FHFA wants new competitors for Frannie - Cowen</a></h4><ul><li>A Federal Housing Finance Agency report is asking Congress to allow it to charter new rivals for Fannie Mae (<a href='https://seekingalpha.com/symbol/FNMA' title='Federal National Mortgage Association'>OTCQB:FNMA</a> <font color='green'>+1.4%</font>) and Freddie Mac (<a href='https://seekingalpha.com/symbol/FMCC' title='Freddie Mac'>OTCQB:FMCC</a> <font color='green'>+1.8%</font>), Cowen's Jaret Seiberg writes in a note to clients.</li><li>The FHFA didn't ask for sovereign backstop on mortgage-backed securities, Seiberg said. Also in the note:</li><li>Sees FHFA proceeding with administrative reform and Congress following up \"with legislation blessing the new structure\";</li><li>Will be a multi-year effort with a better understanding late in the year on \"how the economics of GSE reform will work.\"</li><li>Sees large capital raise.</li><li>Earlier,<em> WSJ </em>wrote about <a href=\"https://seekingalpha.com/news/3470808-fannie-freddie-plus-2_1-percent-fhfa-head-seeks-congressional-action\" target=\"_blank\">FHFA's plans</a> for getting Congress to act on housing finance reform.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/MORL' title='UBS ETRACS Monthly Pay 2x Leveraged Mortgage REIT ETN'>MORL</a>, <a href='https://seekingalpha.com/symbol/REM' title='iShares Mortgage Real Estate Capped ETF'>REM</a>, <a href='https://seekingalpha.com/symbol/MORT' title='VanEck Vectors Mortgage REIT Income ETF'>MORT</a>, <a href='https://seekingalpha.com/symbol/DMO' title='Western Asset Mortgage Defined Opportunity Fund'>DMO</a>, <a href='https://seekingalpha.com/symbol/TSI' title='TCW Strategic Income Fund'>TSI</a>, <a href='https://seekingalpha.com/symbol/PGZ' title='Principal Real Estate Inc Fund'>PGZ</a>, <a href='https://seekingalpha.com/symbol/JLS' title='Nuveen Mortgage Opportunity Term Fund'>JLS</a>, <a href='https://seekingalpha.com/symbol/CMBS' title='iShares CMBS ETF'>CMBS</a>, <a href='https://seekingalpha.com/symbol/FMY' title='First Trust Mortgage Income Fund'>FMY</a>, <a href='https://seekingalpha.com/symbol/JMT' title='Nuveen Mortgage Opportunity Term Fund 2'>JMT</a>, <a href='https://seekingalpha.com/symbol/LMBS' title='First Trust Low Duration Mortgage Opportunities ETF'>LMBS</a>, <a href='https://seekingalpha.com/symbol/MBSD' title='FlexShares Disciplined Duration MBS Index ETF'>MBSD</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3470811\" data-linked=\"FHFA wants new competitors for Frannie - Cowen\" data-tweet=\"$FMCC $FNMA $MORL - FHFA wants new competitors for Frannie - Cowen https://seekingalpha.com/news/3470811-fhfa-wants-new-competitors-for-frannie-cowen?source=tweet\" data-url=\"https://seekingalpha.com/news/3470811-fhfa-wants-new-competitors-for-frannie-cowen\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>68&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470810\" data-ts=\"1560353106\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FSLY\" target=\"_blank\">FSLY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470810-fastlyminus-6-after-quiet-period-expires\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fastly -6% after quiet period expires</a></h4><ul><li>Fastly (NYSE:<a href='https://seekingalpha.com/symbol/FSLY' title='Fastly, Inc.'>FSLY</a>) gets a wave of initiations after its quiet period expired.</li><li>Buy-equivalent starts: BofAML with a $26 target; Credit Suisse at $25; DA Davidson at $26.50; Oppenheimer at $27; Baird at $28; Stifel at $25.</li><li>Hold-equivalent: Citi with a $23 price target and Raymond James.</li><li>Fastly shares are <font color=\"red\">down 5.6%</font> to $21.59.</li><li>FSLY has a Neutral average <a href=\"https://seekingalpha.com/symbol/FSLY/ratings/author-ratings#filter=all\" target=\"_blank\">SA Authors' rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3470810\" data-linked=\"Fastly -6% after quiet period expires\" data-tweet=\"$FSLY - Fastly -6% after quiet period expires https://seekingalpha.com/news/3470810-fastlyminus-6-after-quiet-period-expires?source=tweet\" data-url=\"https://seekingalpha.com/news/3470810-fastlyminus-6-after-quiet-period-expires\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470807\" data-ts=\"1560352271\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEVA\" target=\"_blank\">TEVA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470807-oklahoma-judge-blocks-tevas-85m-settle-in-oklahoma-shares-down-6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oklahoma judge blocks Teva&#39;s $85M settle in Oklahoma; shares down 6%</a></h4><ul><li>Teva Pharmaceutical Industries (<a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a> <font color=\"red\">-5.5%</font>) continues to battle bad news. Bloomberg reports that a district court judge in Oklahoma will not approve the company's $85M settlement over its role in the opioid epidemic there because AG Mike Hunter has not shown that the proceeds will go into the state's treasury as mandated under a recent law.</li><li>Oklahoma lawmakers enacted the legislation after the $270M settlement with Purdue Pharma which will fund research and treatment programs instead of being deposited into the state's coffers.</li><li>It appears unlikely, though, that the issue the TEVA settlement cannot be quickly resolved.</li></ul><div class=\"tiny-share-widget\" data-id=\"3470807\" data-linked=\"Oklahoma judge blocks Teva&#39;s $85M settle in Oklahoma; shares down 6%\" data-tweet=\"$TEVA - Oklahoma judge blocks Teva&#39;s $85M settle in Oklahoma; shares down 6% https://seekingalpha.com/news/3470807-oklahoma-judge-blocks-tevas-85m-settle-in-oklahoma-shares-down-6?source=tweet\" data-url=\"https://seekingalpha.com/news/3470807-oklahoma-judge-blocks-tevas-85m-settle-in-oklahoma-shares-down-6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>108&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470805\" data-ts=\"1560351687\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PES\" target=\"_blank\">PES</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470805-pioneer-energy-gets-nyse-continued-listing-standard-warning\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pioneer Energy gets NYSE continued listing standard warning</a></h4><ul><li>Pioneer Energy Services (<a href='https://seekingalpha.com/symbol/PES' title='Pioneer Energy Services Corp.'>PES</a> <font color='red'>-4.3%</font>) says it received a <a href=\"https://seekingalpha.com/pr/17541871-pioneer-energy-services-receives-continued-listing-standard-notice-nyse\" target=\"_blank\">de-listing warning from the NYSE</a>, as the company's stock does not satisfy one of the exchange's continued listing standards.</li><li>The NYSE requires the average closing price of a listed company's stock be no less than $1.00/share over a consecutive 30 trading-day period; as of Monday, PES's average closing price over the 30 days was $0.89/share.</li><li>PES says it intends to cure the share price deficiency; it has six months to regain compliance.</li></ul><div class=\"tiny-share-widget\" data-id=\"3470805\" data-linked=\"Pioneer Energy gets NYSE continued listing standard warning\" data-tweet=\"$PES - Pioneer Energy gets NYSE continued listing standard warning https://seekingalpha.com/news/3470805-pioneer-energy-gets-nyse-continued-listing-standard-warning?source=tweet\" data-url=\"https://seekingalpha.com/news/3470805-pioneer-energy-gets-nyse-continued-listing-standard-warning\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470803\" data-ts=\"1560351676\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470803-ohr-pharmaceutical-and-biolase-among-healthcare-gainers-novabay-pharmaceuticals-leads-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">OHR Pharmaceutical and BIOLASE among healthcare gainers; NovaBay Pharmaceuticals leads the losers</a></h4><ul><li><b>Gainers: </b>Immuron (NASDAQ:<a href='https://seekingalpha.com/symbol/IMRN' title='Immuron Limited'>IMRN</a>) <font color=\"green\">+31%</font>. Synlogic (NASDAQ:<a href='https://seekingalpha.com/symbol/SYBX' title='Synlogic, Inc.'>SYBX</a>) <font color=\"green\">+22%</font>. BIOLASE (NASDAQ:<a href='https://seekingalpha.com/symbol/BIOL' title='BIOLASE, Inc.'>BIOL</a>) <font color=\"green\">+19%</font>. Tocagen (NASDAQ:<a href='https://seekingalpha.com/symbol/TOCA' title='Tocagen Inc.'>TOCA</a>) <font color=\"green\">+13%</font>. OHR Pharmaceutical (NASDAQ:<a href='https://seekingalpha.com/symbol/OHRP' title='OHR Pharmaceutical, Inc.'>OHRP</a>) <font color=\"green\">+14%</font>.</li><li><b>Losers: </b>NovaBay Pharmaceuticals (NYSEMKT:<a href='https://seekingalpha.com/symbol/NBY' title='NovaBay Pharmaceuticals, Inc.'>NBY</a>) <font color=\"red\">-18%</font>. Jaguar Health (NASDAQ:<a href='https://seekingalpha.com/symbol/JAGX' title='Jaguar Health, Inc.'>JAGX</a>) <font color=\"red\">-18%</font>. Motus GI Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/MOTS' title='Motus GI Holdings, Inc.'>MOTS</a>) <font color=\"red\">-15%</font>. ContraVir Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CTRV' title='ContraVir Pharmaceuticals, Inc.'>CTRV</a>) <font color=\"red\">-13%</font>. Novus Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/NVUS' title='Novus Therapeutics, Inc.'>NVUS</a>) <font color=\"red\">-10%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3470803\" data-linked=\"OHR Pharmaceutical and BIOLASE among healthcare gainers; NovaBay Pharmaceuticals leads the losers\" data-tweet=\"$IMRN $SYBX $BIOL - OHR Pharmaceutical and BIOLASE among healthcare gainers; NovaBay Pharmaceuticals leads the losers https://seekingalpha.com/news/3470803-ohr-pharmaceutical-and-biolase-among-healthcare-gainers-novabay-pharmaceuticals-leads-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3470803-ohr-pharmaceutical-and-biolase-among-healthcare-gainers-novabay-pharmaceuticals-leads-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470801\" data-ts=\"1560351610\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HOFT\" target=\"_blank\">HOFT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470801-post-earnings-slide-for-hooker-furniture\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Post-earnings slide for Hooker Furniture</a></h4><ul> <li>Hooker Furniture (<a href='https://seekingalpha.com/symbol/HOFT' title='Hooker Furniture Corporation'>HOFT</a> <font color='red'>-14.9%</font>) slides after missing EPS estimates with its Q1 report.</li> <li>The company points to \"cost-related issues\" with the Home Meridian segment and notes reduced demand and soft retail conditions across the home furnishings industry.</li> <li>\"We are addressing all these challenges with strategies to improve profitably in all our businesses. We expect the challenges to persist throughout the summer, but are optimistic about the fall selling season,\" says CEO Paul Toms.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3470697-hooker-furniture-eps-misses-0_06-beats-revenue\" target=\"_blank\">Hooker Furniture EPS misses by $0.06, beats on revenue</a> (June 12)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3470801\" data-linked=\"Post-earnings slide for Hooker Furniture\" data-tweet=\"$HOFT - Post-earnings slide for Hooker Furniture https://seekingalpha.com/news/3470801-post-earnings-slide-for-hooker-furniture?source=tweet\" data-url=\"https://seekingalpha.com/news/3470801-post-earnings-slide-for-hooker-furniture\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470793\" data-ts=\"1560350999\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEVA\" target=\"_blank\">TEVA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470793-teva-hits-19-year-low-on-continued-pricing-pressure\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Teva hits 19-year low on continued pricing pressure</a></h4><ul><li>Teva Pharmaceutical Industries (<a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a> <font color=\"red\">-4.2%</font>) slumps on modestly higher volume. Shares are now exchanging hands at the lowest prices in 19 years. The stock continues to fight pricing headwinds, the continued erosion of Copaxone sales (down 56% in Q1) and its potential exposure from opioid litigation.</li><li>Other generic players are also in the red.</li><li>Selected tickers: Dr. Reddy's Labs (<a href='https://seekingalpha.com/symbol/RDY' title='Dr. Reddy&#39;s Laboratories Limited'>RDY</a> <font color=\"red\">-1.3%</font>), Perrigo (<a href='https://seekingalpha.com/symbol/PRGO' title='Perrigo Company plc'>PRGO</a> <font color=\"red\">-0.6%</font>), Mylan (<a href='https://seekingalpha.com/symbol/MYL' title='Mylan N.V.'>MYL</a> <font color=\"red\">-1.6%</font>), Mallinckrodt (<a href='https://seekingalpha.com/symbol/MNK' title='Mallinckrodt plc'>MNK</a> <font color=\"red\">-0.8%</font>), Lannett Company (<a href='https://seekingalpha.com/symbol/LCI' title='Lannett Company, Inc.'>LCI</a> <font color=\"red\">-4.4%</font>), Endo International (<a href='https://seekingalpha.com/symbol/ENDP' title='Endo International plc'>ENDP</a> <font color=\"red\">-1.9%</font>), Collegium Pharmaceutical (<a href='https://seekingalpha.com/symbol/COLL' title='Collegium Pharmaceutical, Inc.'>COLL</a> <font color=\"red\">-0.9%</font>), Bausch Health Companies (<a href='https://seekingalpha.com/symbol/BHC' title='Bausch Health Companies Inc.'>BHC</a> <font color=\"red\">-3.2%</font>), Akorn (<a href='https://seekingalpha.com/symbol/AKRX' title='Akorn, Inc.'>AKRX</a> <font color=\"red\">-1.2%</font>), Aclaris Therapeutics (<a href='https://seekingalpha.com/symbol/ACRS' title='Aclaris Therapeutics, Inc.'>ACRS</a> <font color=\"red\">-2.7%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3470793\" data-linked=\"Teva hits 19-year low on continued pricing pressure\" data-tweet=\"$TEVA $RDY $PRGO - Teva hits 19-year low on continued pricing pressure https://seekingalpha.com/news/3470793-teva-hits-19-year-low-on-continued-pricing-pressure?source=tweet\" data-url=\"https://seekingalpha.com/news/3470793-teva-hits-19-year-low-on-continued-pricing-pressure\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>82&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470789\" data-ts=\"1560350600\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470789-wiley-signs-ohio-library-consortium-to-open-access-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wiley signs Ohio library consortium to open access deal</a></h4><ul>   <li>John Wiley &amp; Sons (<a href='https://seekingalpha.com/symbol/JW.A' title='John Wiley & Sons, Inc.'>JW.A</a> <font color=\"green\">+2.2%</font>, <a href='https://seekingalpha.com/symbol/JW.B' title='John Wiley & Sons, Inc.'>JW.B</a> <font color=\"green\">+5.7%</font>) has signed a <a href=\"https://seekingalpha.com/pr/17542342-ohiolink-breaks-new-ground-creating-central-fund-open-access-publications-wiley\" target=\"_blank\">Wiley Open Access Account agreement</a> with OhioLINK, a library consortium serving 118 libraries and 89 Ohio colleges and universities.</li>    <li>That allows for researchers affiliated with OhioLINK to use a central fund for article publication charges.</li>    <li>The move builds on a longstanding relationship with OhioLINK, Wiley says.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3470789\" data-linked=\"Wiley signs Ohio library consortium to open access deal\" data-tweet=\"$JW.A $JW.B - Wiley signs Ohio library consortium to open access deal https://seekingalpha.com/news/3470789-wiley-signs-ohio-library-consortium-to-open-access-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3470789-wiley-signs-ohio-library-consortium-to-open-access-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:43 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470786\" data-ts=\"1560350028\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARGT\" target=\"_blank\">ARGT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470786-argentinas-macri-chooses-moderate-running-mate-lifting-countrys-stocks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Argentina&#39;s Macri chooses moderate running mate, lifting country&#39;s stocks</a></h4><ul><li>Argentina-based stocks enjoy a boost after Pres. Macri <a href=\"https://www.reuters.com/article/us-argentina-politics/argentinas-macri-chooses-moderate-running-mate-in-move-to-broaden-base-idUSKCN1TC2HE\" target=\"_blank\">chose a moderate senator</a> as his vice presidential candidate in the October elections; polls have showed Macri narrowly trailing the main opposition ticket.</li><li>Macri became president in 2015, and Miguel Pichetto helped reach a final deal with holders of  Argentine sovereign bonds, which was key to loosening up access to  international financial markets.</li><li><a href='https://seekingalpha.com/symbol/TGS' title='Transportadora de Gas del Sur S.A.'>TGS</a> <font color=\"green\">+8.4%</font>, <a href='https://seekingalpha.com/symbol/CEPU' title='Central Puerto S.A.'>CEPU</a> <font color=\"green\">+8.4%</font>, <a href='https://seekingalpha.com/symbol/TEO' title='Telecom Argentina S.A.'>TEO</a> <font color=\"green\">+7.6%</font>, <a href='https://seekingalpha.com/symbol/PAM' title='Pampa Energía S.A.'>PAM</a> <font color=\"green\">+6.7%</font>, <a href='https://seekingalpha.com/symbol/IRS' title='IRSA Inversiones y Representaciones Sociedad Anónima'>IRS</a> <font color=\"green\">+6.3%</font>, <a href='https://seekingalpha.com/symbol/GGAL' title='Grupo Financiero Galicia S.A.'>GGAL</a> <font color=\"green\">+6%</font>, <a href='https://seekingalpha.com/symbol/BFR' title='BBVA Banco Francés S.A.'>BFR</a> <font color=\"green\">+5.9%</font>, <a href='https://seekingalpha.com/symbol/EDN' title='Empresa Distribuidora y Comercializadora Norte Sociedad Anónima'>EDN</a> <font color=\"green\">+5.4%</font>, <a href='https://seekingalpha.com/symbol/SUPV' title='Grupo Supervielle S.A.'>SUPV</a> <font color=\"green\">+4.8%</font>, <a href='https://seekingalpha.com/symbol/CRESY' title='Cresud Sociedad Anónima Comercial, Inmobiliaria, Financiera y Agropecuaria'>CRESY</a> <font color=\"green\">+4%</font>, <a href='https://seekingalpha.com/symbol/BMA' title='Banco Macro S.A.'>BMA</a> <font color=\"green\">+3.9%</font>, <a href='https://seekingalpha.com/symbol/YPF' title='YPF Sociedad Anónima'>YPF</a> <font color=\"green\">+3.7%</font>, <a href='https://seekingalpha.com/symbol/ARGT' title='Global X MSCI Argentina ETF'>ARGT</a> <font color=\"green\">+3.3%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3470786\" data-linked=\"Argentina&#39;s Macri chooses moderate running mate, lifting country&#39;s stocks\" data-tweet=\"$ARGT $TGS $CEPU - Argentina&#39;s Macri chooses moderate running mate, lifting country&#39;s stocks https://seekingalpha.com/news/3470786-argentinas-macri-chooses-moderate-running-mate-lifting-countrys-stocks?source=tweet\" data-url=\"https://seekingalpha.com/news/3470786-argentinas-macri-chooses-moderate-running-mate-lifting-countrys-stocks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:33 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470784\" data-ts=\"1560349908\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470784-crude-inventory-builds-slightly\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Crude inventory builds slightly</a></h4><ul><li><a href=\"http://ir.eia.gov/wpsr/wpsrsummary.pdf\" target=\"_blank\">EIA Petroleum Inventories:</a> Crude <strong>+2.2M</strong> barrels vs. -0.5M consensus, +6.8M last week.</li><li>Gasoline <strong>+0.8M</strong> barrels vs. +0.7M consensus, +3.2M last week.</li><li>Distillates <strong>-1.0</strong><strong>M</strong> barrels vs. +1.1M consensus, +4.6M last week.</li><li>Futures <font color=\"red\">-2.18%</font> to $52.11.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Ultra Bloomberg Crude Oil ETF'>UCO</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/BNO' title='The United States Brent Oil ETF, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/DBO' title='Invesco DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/USL' title='The United States 12 Month Oil ETF, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/SZO' title='DB Crude Oil Short ETN'>SZO</a>, <a href='https://seekingalpha.com/symbol/OLO' title='DB Crude Oil Long ETN'>OLO</a>, <a href='https://seekingalpha.com/symbol/OLEM' title='iPath Pure Beta Crude Oil ETN'>OLEM</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3470784\" data-linked=\"Crude inventory builds slightly\" data-tweet=\"$USO $OIL $UCO - Crude inventory builds slightly https://seekingalpha.com/news/3470784-crude-inventory-builds-slightly?source=tweet\" data-url=\"https://seekingalpha.com/news/3470784-crude-inventory-builds-slightly\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>52&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470781\" data-ts=\"1560349269\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TS\" target=\"_blank\">TS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470781-tenaris-shareholders-to-consider-delisting-from-buenos-aires-exchange\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tenaris shareholders to consider delisting from Buenos Aires exchange</a></h4><ul><li>Tenaris (<a href='https://seekingalpha.com/symbol/TS' title='Tenaris S.A.'>TS</a> <font color='red'>-4.1%</font>) tumbles in early trade after calling a general shareholder meeting to consider the <a href=\"https://seekingalpha.com/pr/17541639-tenaris-announces-convening-general-shareholders-meeting-consider-delisting-shares-buenos\" target=\"_blank\">delisting of its shares</a> from the Buenos Aires stock exchange.</li><li>TS says a voluntary withdrawal would permit it to delist from the Bolsas y Mercados Argentinos without making a delisting public tender offer.</li><li>TS also <a href=\"https://seekingalpha.com/news/3470698-tenaris-cfo-carlos-depart-mondolo-promoted-cfo\" target=\"_blank\">promoted</a> Alicia Mondolo to CFO with the resignation of current CFO Edgardo Carlos.</li></ul><div class=\"tiny-share-widget\" data-id=\"3470781\" data-linked=\"Tenaris shareholders to consider delisting from Buenos Aires exchange\" data-tweet=\"$TS - Tenaris shareholders to consider delisting from Buenos Aires exchange https://seekingalpha.com/news/3470781-tenaris-shareholders-to-consider-delisting-from-buenos-aires-exchange?source=tweet\" data-url=\"https://seekingalpha.com/news/3470781-tenaris-shareholders-to-consider-delisting-from-buenos-aires-exchange\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470775\" data-ts=\"1560348710\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CARG\" target=\"_blank\">CARG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470775-oppenheimer-still-positive-on-cargurus\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oppenheimer still positive on CarGurus</a></h4><ul> <li>Oppenheimer updates on CarGurus (<a href='https://seekingalpha.com/symbol/CARG' title='CarGurus, Inc.'>CARG</a> <font color='red'>-0.8%</font>) after</li> <li>\"We remain buyers of CARG following yesterday's investor day where management presented a long-term roadmap to increase domestic AARSD, drive global expansion, and generate more value around the car ownership lifecycle.\"</li> <li>\"CARG appears well equipped to manage through its 12th Google algorithm change, and we view decelerating US traffic as a function of much tougher comps versus significant disruption to traffic acquisition dynamics. Additionally, we believe 20%-plus connection growth, higher product attach rates, and 7x US dealer ROI are strong indicators of upside to \u201819 US AARSD that can offset the short narrative of higher reliance on paid traffic channels.\"</li> <li>Oppenheimer keeps an Outperform rating on CARG vs. the Sell-side consensus of <a href=\"https://seekingalpha.com/symbol/CARG/ratings/sell-side-ratings\" target=\"_blank\">Outperform</a> and <a href=\"https://seekingalpha.com/symbol/CARG/ratings/quant-ratings\" target=\"_blank\">Quant Rating</a> of Neutral.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3470775\" data-linked=\"Oppenheimer still positive on CarGurus\" data-tweet=\"$CARG - Oppenheimer still positive on CarGurus https://seekingalpha.com/news/3470775-oppenheimer-still-positive-on-cargurus?source=tweet\" data-url=\"https://seekingalpha.com/news/3470775-oppenheimer-still-positive-on-cargurus\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470773\" data-ts=\"1560348325\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZLAB\" target=\"_blank\">ZLAB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470773-zai-lab-gets-nod-in-macau-to-sell-zejula-for-ovarian-cancer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zai Lab gets nod in Macau to sell Zejula for ovarian cancer</a></h4><ul><li>Zai Lab Limited (<a href='https://seekingalpha.com/symbol/ZLAB' title='Zai Lab Limited'>ZLAB</a> <font color=\"green\">+1.1%</font>) <a href=\"https://seekingalpha.com/pr/17542460-zai-lab-announces-approval-commercialize-zejula-niraparib-macau-patients-relapsed-ovarian\" target=\"_blank\">announces </a>that it has received regulatory approval to commercialize Zejula (niraparib) in Macau for the treatment of adult patients with with platinum-sensitive relapsed high grade serous epithelial ovarian cancer who are in a complete or partial response to platinum-based chemotherapy.</li><li>The company in-licensed the PARP inhibitor from TESARO (<a href='https://seekingalpha.com/symbol/GSK' title='GlaxoSmithKline plc'>GSK</a> <font color=\"green\">+0.9%</font>) in September 2016 for the China market.</li></ul><div class=\"tiny-share-widget\" data-id=\"3470773\" data-linked=\"Zai Lab gets nod in Macau to sell Zejula for ovarian cancer\" data-tweet=\"$ZLAB $GSK - Zai Lab gets nod in Macau to sell Zejula for ovarian cancer https://seekingalpha.com/news/3470773-zai-lab-gets-nod-in-macau-to-sell-zejula-for-ovarian-cancer?source=tweet\" data-url=\"https://seekingalpha.com/news/3470773-zai-lab-gets-nod-in-macau-to-sell-zejula-for-ovarian-cancer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:05 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470765\" data-ts=\"1560347574\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMRN\" target=\"_blank\">IMRN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470765-immuron-up-11-on-encouraging-travelan-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Immuron up 11% on encouraging Travelan data</a></h4><ul><li>Thinly traded nano cap Immuron Limited (<a href='https://seekingalpha.com/symbol/IMRN' title='Immuron Limited'>IMRN</a> <font color=\"green\">+11.4%</font>) is up in early trade on the heels of <a href=\"https://seekingalpha.com/pr/17541929-us-department-defense-reports-final-results-travelan-shigellosis-challenge-study\" target=\"_blank\">encouraging results</a> from a <em>Shigella</em> challenge study of in non-human primates aimed at assessing the effectiveness of Trevalen for preventing dysentery.</li><li>12 juvenile rhesus monkeys were segregated into two groups, eight who received Travalen and four who received placebo prior to oral challenge with <em><a href=\"https://www.cdc.gov/shigella/index.html\" target=\"_blank\">Shigella</a></em>, a bacterial group that causes stomach cramps, fever and diarrhea.</li><li>All four monkeys in the placebo group developed acute dysentery within 24 - 36 hours of <em>Shigella </em>challenge.</li><li>Six of the eight monkeys in the Travalen group showed no signs of dysentery while two \"displayed\" signs of dysentery.</li><li>The results were reported by Bangkok, Thailand-based U.S. Armed Forces Research Institute of Medical Sciences, a laboratory of the Walter Reed Army Institute of Research.</li><li>The active ingredient in <a href=\"https://www.immuron.com.au/travelan/\" target=\"_blank\">Travalen </a>is hyperimmune bovine colostrum powder which binds to <em>Enterotoxigenic E. coli, </em>the most common cause of traveler's diarrhea. It is also designed to reduce the risk of infection by other diarrhea-related bacteria like <em>Shigella </em>and <em>Salmonella</em>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3470765\" data-linked=\"Immuron up 11% on encouraging Travelan data\" data-tweet=\"$IMRN - Immuron up 11% on encouraging Travelan data https://seekingalpha.com/news/3470765-immuron-up-11-on-encouraging-travelan-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3470765-immuron-up-11-on-encouraging-travelan-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:52 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470763\" data-ts=\"1560346982\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470763-zillow-trading-risk-reward-balance-raymond-james\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zillow trading at risk/reward balance - Raymond James</a></h4><ul><li>Raymond James analyst Justin Patterson says the \"rapid expansion\" of Zillow's (<a href='https://seekingalpha.com/symbol/Z' title='Zillow Group, Inc.'>Z</a> <font color='green'>+0.7%</font>)(<a href='https://seekingalpha.com/symbol/ZG' title='Zillow Group, Inc.'>ZG</a> <font color='green'>+0.2%</font>) iBuyer category appears priced into the stock.</li><li>Patterson writes that further gains would have to come from either \"a return to mid-to-high teens Premier Agent revenue growth and margin expansion for the core business\" or multiple expansion for both businesses.</li><li>Raymond James maintains a Market Perform rating and a $45 fair value for Zillow.</li><li>Zillow has a Neutral <a href=\"https://seekingalpha.com/symbol/ZG/ratings/quant-ratings\" target=\"_blank\">Quant rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3470763\" data-linked=\"Zillow trading at risk/reward balance - Raymond James\" data-tweet=\"$Z $ZG - Zillow trading at risk/reward balance - Raymond James https://seekingalpha.com/news/3470763-zillow-trading-risk-reward-balance-raymond-james?source=tweet\" data-url=\"https://seekingalpha.com/news/3470763-zillow-trading-risk-reward-balance-raymond-james\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470757\" data-ts=\"1560346412\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MKTX\" target=\"_blank\">MKTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470757-marketaxessminus-2_1-after-buckingham-cuts-on-stock-valuation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MarketAxess -2.1% after Buckingham cuts on stock valuation</a></h4><ul><li>MarketAxess (NASDAQ:<a href='https://seekingalpha.com/symbol/MKTX' title='MarketAxess Holdings Inc.'>MKTX</a>) <font color=\"red\">slides 2.1%</font> after Buckingham Research cuts its rating to underperform from neutral, explaining that investors' enthusiasm over the company's growth prospects \"has become excessive.\"</li><li>YTD, MKTX<a href=\"https://seekingalpha.com/symbol/MKTX/momentum/performance\" target=\"_blank\"> has risen </a>53% vs. 3.73% for the S&amp;P 500 over the same period.</li><li>Analyst Hugh Miller takes bearish view due to the stock's valuation; calls the company \"well managed\" and says it's \"best positioned to benefit from the electronification of the coporate bond markets.\"</li><li><a href=\"https://seekingalpha.com/symbol/MKTX/ratings/quant-ratings\" target=\"_blank\">Quant Rating </a>Neutral; <a href=\"https://seekingalpha.com/symbol/MKTX/ratings/sell-side-ratings\" target=\"_blank\">Sell-side average rating</a> Hold (11 Hold, 1 Underperform)</li></ul><div class=\"tiny-share-widget\" data-id=\"3470757\" data-linked=\"MarketAxess -2.1% after Buckingham cuts on stock valuation\" data-tweet=\"$MKTX - MarketAxess -2.1% after Buckingham cuts on stock valuation https://seekingalpha.com/news/3470757-marketaxessminus-2_1-after-buckingham-cuts-on-stock-valuation?source=tweet\" data-url=\"https://seekingalpha.com/news/3470757-marketaxessminus-2_1-after-buckingham-cuts-on-stock-valuation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470747\" data-ts=\"1560346135\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INTC\" target=\"_blank\">INTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470747-qualcommminus-2_8-apple-mulls-intel-modem-purchase\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Qualcomm -2.8% as Apple mulls Intel modem purchase</a></h4><ul><li>Bernstein cites <a href=\"https://www.theinformation.com/articles/apple-discusses-acquisition-of-intels-german-modem-unit?\" target=\"_blank\">reports of talks</a> for Intel (NASDAQ:<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a>) to sell its German smartphone business to Apple (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) and notes it would be a \"reasonably cheap\" move for Apple.</li><li>Analyst Stacy Rasgon writes the deal's eventual impact on Qualcomm (NASDAQ:<a href='https://seekingalpha.com/symbol/QCOM' title='QUALCOMM Incorporated'>QCOM</a>) would depend on whether Apple can develop a viable solution on a suitable timeline.</li><li>In other Qualcomm news, Rasgon notes that new filings in the FTC case indicate the company is appealing and wants a stay of injunctive relief.</li><li>Qualcomm shares are <font color=\"red\">down 2.8%</font> pre-market. Intel and Apple shares are <font color=\"red\">down 0.5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3470747\" data-linked=\"Qualcomm -2.8% as Apple mulls Intel modem purchase\" data-tweet=\"$INTC $AAPL $QCOM - Qualcomm -2.8% as Apple mulls Intel modem purchase https://seekingalpha.com/news/3470747-qualcommminus-2_8-apple-mulls-intel-modem-purchase?source=tweet\" data-url=\"https://seekingalpha.com/news/3470747-qualcommminus-2_8-apple-mulls-intel-modem-purchase\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>40&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470744\" data-ts=\"1560345766\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CPRX\" target=\"_blank\">CPRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470744-catalyst-sues-fda-over-approval-of-firdapse-competitor-in-lems\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Catalyst sues FDA over approval of Firdapse competitor in LEMS</a></h4><ul><li>Citing violations of its own regulations, Catalyst Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CPRX' title='Catalyst Pharmaceuticals, Inc.'>CPRX</a>) is suing the FDA over its recent approval (May 6) of Jacobus Pharmaceutical Company's Ruzurgi (amifampridine) for the treatment of children with an autoimmune disorder called <a href=\"https://www.mda.org/disease/lambert-eaton-myasthenic-syndrome\" target=\"_blank\">Lambert-Eaton syndrome</a> &#40;LEMS&#41;.</li><li>The agency approved Catalyst's Firdapse (amifampridine) for LEMS in November 2018 under Orphan Drug status which is supposed to provide a seven-year period of market exclusivity in the U.S. for the indication.</li><li>Shares are down <font color=\"red\">2%</font> premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3470744\" data-linked=\"Catalyst sues FDA over approval of Firdapse competitor in LEMS\" data-tweet=\"$CPRX - Catalyst sues FDA over approval of Firdapse competitor in LEMS https://seekingalpha.com/news/3470744-catalyst-sues-fda-over-approval-of-firdapse-competitor-in-lems?source=tweet\" data-url=\"https://seekingalpha.com/news/3470744-catalyst-sues-fda-over-approval-of-firdapse-competitor-in-lems\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470740\" data-ts=\"1560345391\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470740-sybx-mat-among-premarket-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SYBX, MAT among premarket gainers</a></h4><ul><li>Synlogic (NASDAQ:<a href='https://seekingalpha.com/symbol/SYBX' title='Synlogic, Inc.'>SYBX</a>) <font color=\"green\">+26%</font> as Ginkgo Bioworks to <a href=\"https://seekingalpha.com/news/3470656-ginkgo-bioworks-invest-80m-synlogic-premium\" target=\"_blank\">invest $80M</a>.</li><li>Bridgeline Digital (NASDAQ:<a href='https://seekingalpha.com/symbol/BLIN' title='Bridgeline Digital, Inc.'>BLIN</a>) <font color=\"green\">+19%</font> as seven new eCommerce brands have <a href=\"https://seekingalpha.com/pr/17542402-international-ecommerce-brands-recently-select-celebros-natural-language-search-bridgeline\" target=\"_blank\">selected Celebros</a> search by Bridgeline to power their customer search and merchandising experiences.</li><li>MagnaChip Semiconductor (NYSE:<a href='https://seekingalpha.com/symbol/MX' title='MagnaChip Semiconductor Corporation'>MX</a>) <font color=\"green\">+20%</font> +13.8% on <a href=\"https://seekingalpha.com/news/3470593-magnachip-plus-13_8-percent-raised-guidance\" target=\"_blank\">raised guidance</a>.</li><li>Netshoes (NYSE:<a href='https://seekingalpha.com/symbol/NETS' title='Netshoes &#40;Cayman&#41; Limited'>NETS</a>) <font color=\"green\">+15%</font>.</li><li>Axovant Gene Therapies (NASDAQ:<a href='https://seekingalpha.com/symbol/AXGT' title='Axovant Gene Therapies Ltd.'>AXGT</a>) <font color=\"green\">+9%</font> on <a href=\"https://seekingalpha.com/news/3470571-axovant-gene-therapies-reports-q4-results\" target=\"_blank\">Q4 results</a>.</li><li>CymaBay Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/CBAY' title='CymaBay Therapeutics, Inc.'>CBAY</a>) <font color=\"green\">+8%</font> on <a href=\"https://seekingalpha.com/news/3470612-cymabay-plus-4_8-percent-raymond-james-fades-45-percent-sell\" target=\"_blank\">positive upgrade</a>.</li><li>Hancock Jaffe Laboratories (NASDAQ:<a href='https://seekingalpha.com/symbol/HJLI' title='Hancock Jaffe Laboratories, Inc.'>HJLI</a>) <font color=\"green\">+10%</font> on <a href=\"https://seekingalpha.com/pr/17542415-hancock-jaffe-announces-pricing-public-offering-common-stock\" target=\"_blank\">pricing</a> of common stock.</li><li>Neptune Wellness Solutions (NASDAQ:<a href='https://seekingalpha.com/symbol/NEPT' title='Neptune Wellness Solutions Inc.'>NEPT</a>) <font color=\"green\">+6%</font> on services <a href=\"https://seekingalpha.com/news/3470657-neptune-plus-8-percent-premarket-services-deal-green-organic-dutchman\" target=\"_blank\">deal</a> with The Green Organic Dutchman.</li><li>Mizuho Financial (NYSE:<a href='https://seekingalpha.com/symbol/MFG' title='Mizuho Financial Group, Inc.'>MFG</a>) <font color=\"green\">+7%</font>.</li><li>Mattel (NASDAQ:<a href='https://seekingalpha.com/symbol/MAT' title='Mattel, Inc.'>MAT</a>) <font color=\"green\">+6%</font> on <a href=\"https://seekingalpha.com/news/3470615-mattel-rejects-another-merger-bid-mga-entertainment-la-times\" target=\"_blank\">rejecting</a> another merger bid from MGA Entertainment - LA Times.</li><li>TheStreet (NASDAQ:<a href='https://seekingalpha.com/symbol/TST' title='TheStreet, Inc.'>TST</a>) <font color=\"green\">+7% </font>on <a href=\"https://seekingalpha.com/news/3470724-thestreet-agrees-sale\" target=\"_blank\">agreeing</a> to sale.</li></ul><div class=\"tiny-share-widget\" data-id=\"3470740\" data-linked=\"SYBX, MAT among premarket gainers\" data-tweet=\"$SYBX $BLIN $MX - SYBX, MAT among premarket gainers https://seekingalpha.com/news/3470740-sybx-mat-among-premarket-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3470740-sybx-mat-among-premarket-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:16 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470739\" data-ts=\"1560345306\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KIRK\" target=\"_blank\">KIRK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470739-kirklandsplus-2-on-insider-buying-action\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kirkland&#39;s +2% on insider buying action</a></h4><ul> <li>Kirkland's (NASDAQ:<a href='https://seekingalpha.com/symbol/KIRK' title='Kirkland&#39;s, Inc.'>KIRK</a>) tracks higher after the company discloses that CEO Steve Woodward acquired 43K shares.</li> <li>Shares of Kirkland's are <font color=\"green\">up 1.78%</font> premarket to $2.29</li> <li><a href=\"https://seekingalpha.com/filing/4529278\" target=\"_blank\">SEC Form 4</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3470739\" data-linked=\"Kirkland&#39;s +2% on insider buying action\" data-tweet=\"$KIRK - Kirkland&#39;s +2% on insider buying action https://seekingalpha.com/news/3470739-kirklandsplus-2-on-insider-buying-action?source=tweet\" data-url=\"https://seekingalpha.com/news/3470739-kirklandsplus-2-on-insider-buying-action\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470734\" data-ts=\"1560344943\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470734-play-and-sdrl-among-premarket-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PLAY and SDRL among premarket losers</a></h4><ul><li>Dave &amp; Buster's Entertainment (NASDAQ:<a href='https://seekingalpha.com/symbol/PLAY' title='Dave & Buster&#39;s Entertainment, Inc.'>PLAY</a>) <font color=\"red\">-17%</font> on <a href=\"https://seekingalpha.com/news/3470563-dave-and-busters-eps-misses-0_01-misses-revenue\" target=\"_blank\">Q1 earnings</a>.</li><li>ContraVir Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CTRV' title='ContraVir Pharmaceuticals, Inc.'>CTRV</a>) <font color=\"red\">-15%</font> on filing for <a href=\"https://seekingalpha.com/news/3470668-contravir-files-equity-offering\" target=\"_blank\">equity offering</a>.</li><li>Seadrill (NYSE:<a href='https://seekingalpha.com/symbol/SDRL' title='Seadrill Limited'>SDRL</a>) <font color=\"red\">-10%</font>.</li><li>Curis (NASDAQ:<a href='https://seekingalpha.com/symbol/CRIS' title='Curis, Inc.'>CRIS</a>) <font color=\"red\">-6%</font>.</li><li>Jaguar Health (NASDAQ:<a href='https://seekingalpha.com/symbol/JAGX' title='Jaguar Health, Inc.'>JAGX</a>) <font color=\"red\">-4%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3470734\" data-linked=\"PLAY and SDRL among premarket losers\" data-tweet=\"$PLAY $HEPA $SDRL - PLAY and SDRL among premarket losers https://seekingalpha.com/news/3470734-play-and-sdrl-among-premarket-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3470734-play-and-sdrl-among-premarket-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470731\" data-ts=\"1560344792\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PLAY\" target=\"_blank\">PLAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470731-sell-side-retreat-on-dave-busters-entertainment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sell-side retreat on Dave &amp; Buster&#39;s Entertainment</a></h4><ul> <li>A wave of analyst downgrades are arriving in on Dave &amp; Buster's Entertainment (NASDAQ:<a href='https://seekingalpha.com/symbol/PLAY' title='Dave & Buster&#39;s Entertainment, Inc.'>PLAY</a>) following a <a href=\"https://seekingalpha.com/news/3470578-dave-and-busters-minus-16-percent-guidance-cut\" target=\"_blank\">weak guidance update</a> from the entertainment chain.</li> <li>Wells Fargo points to lowered confidence in D&amp;B's ability to sustainably drive SSS growth without additional margin erosion as it downgrades to Market Perform from Outperform.</li><li>WF: \"While we believe the company\u2019s strategy to drive new store growth (a long-term value creator) vs. focusing the majority of its energy on SSS growth (a near-term barometer of long-term value creation) is ultimately the proper business decision (given the 50%+ year-1 cash-on-cash returns for new stores over the past 6+ years), we believe that public equity investors will continue to not recognize this value driver without the two engines firing simultaneously.\"</li> <li>SunTrust and Gordon Haskett both dropped their ratings on PLAY to Hold, with price targets of $47 and $48 respectively. The sell-side community went into the D&amp;B earnings report with a consensus Outperform rating on the stock and Seeking Alpha's <a href=\"https://seekingalpha.com/symbol/PLAY/ratings/quant-ratings\" target=\"_blank\">Quant rating</a> is still flashing Bullish even after the report dropped.</li><li>Shares of Dave &amp; Buster's are <font color=\"red\">down 16.97%</font> premarket to $42.80. The 52-week low is $42.78.</li></ul><div class=\"tiny-share-widget\" data-id=\"3470731\" data-linked=\"Sell-side retreat on Dave &amp; Buster&#39;s Entertainment\" data-tweet=\"$PLAY - Sell-side retreat on Dave &amp; Buster&#39;s Entertainment https://seekingalpha.com/news/3470731-sell-side-retreat-on-dave-busters-entertainment?source=tweet\" data-url=\"https://seekingalpha.com/news/3470731-sell-side-retreat-on-dave-busters-entertainment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470724\" data-ts=\"1560344028\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TST\" target=\"_blank\">TST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470724-thestreet-agrees-to-sale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TheStreet agrees to a sale</a></h4><ul><li>The buyer is TheMaven (<a href='https://seekingalpha.com/symbol/MVEN' title='TheMaven, Inc.'>OTCPK:MVEN</a>), a coalition of content producers operating on a shared digital publishing, advertising and distribution platform.</li><li>A subsidiary of TheMaven will acquire all of the outstanding common shares of TheStreet (NASDAQ:<a href='https://seekingalpha.com/symbol/TST' title='TheStreet, Inc.'>TST</a>) for $16.5M in cash.</li><li>In addition to a pro-rata portion of the Purchase Price, shareholders of TheStreet will receive additional consideration in connection with the closing of the merger transaction consisting of, (1) a special cash distribution equal to the cash held by the company immediately prior to the closing less any excluded liabilities as agreed to between the parties; and (2) a contingent value right, or CVR, which will entitle each holder to receive a pro-rata portion of the expected release of funds from the outstanding escrow agreements entered into by the company in connection with the sale of each its RateWatch and boardEx/TheDeal businesses CVRs. That works out to a price of $6.19-$6.47 per <a href='https://seekingalpha.com/symbol/TST' title='TheStreet, Inc.'>TST</a> share vs. yesterday's close of $5.68.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17542177-thestreet-completes-strategic-sale-process-entering-agreement-acquired-maven\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3470724\" data-linked=\"TheStreet agrees to a sale\" data-tweet=\"$TST $MVEN $MVEN - TheStreet agrees to a sale https://seekingalpha.com/news/3470724-thestreet-agrees-to-sale?source=tweet\" data-url=\"https://seekingalpha.com/news/3470724-thestreet-agrees-to-sale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470719\" data-ts=\"1560343546\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PBR\" target=\"_blank\">PBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470719-petrobras-hikes-five-year-investment-plan-to-105b\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Petrobras hikes five-year investment plan to $105B</a></h4><ul><li>Petrobras (NYSE:<a href='https://seekingalpha.com/symbol/PBR' title='Petróleo Brasileiro S.A. - Petrobras'>PBR</a>) plans to <a href=\"https://www.reuters.com/article/us-petrobras-investment-ceo/petrobras-to-boost-five-year-investment-plan-to-105-billion-ceo-idUSKCN1TD00B\" target=\"_blank\">invest $105B within five years</a> and divest as much as $35B in the same period, CEO Roberto Castello Branco says.</li><li>The figures, cited during a hearing at the lower house of Brazil's Congress, exceed the company's $84B investment plan for 2019-23 announced before Castello Branco became CEO.</li><li>The new divestiture plan also is higher than the $26.9B previously disclosed by the company.</li><li>PBR <font color=\"red\">-1.7%</font> pre-market.</li></ul><div class=\"tiny-share-widget\" data-id=\"3470719\" data-linked=\"Petrobras hikes five-year investment plan to $105B\" data-tweet=\"$PBR - Petrobras hikes five-year investment plan to $105B https://seekingalpha.com/news/3470719-petrobras-hikes-five-year-investment-plan-to-105b?source=tweet\" data-url=\"https://seekingalpha.com/news/3470719-petrobras-hikes-five-year-investment-plan-to-105b\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:45 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470718\" data-ts=\"1560343457\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRBP\" target=\"_blank\">CRBP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470718-corbus-up-3-premarket-on-positive-lenabasum-data-in-rare-autoimmune-disorders\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Corbus up 3% premarket on positive lenabasum data in rare autoimmune disorders</a></h4><ul><li>Corbus Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CRBP' title='Corbus Pharmaceuticals Holdings, Inc.'>CRBP</a>) perks up <font color=\"green\">3%</font> premarket on light volume in response to <a href=\"https://seekingalpha.com/pr/17542145-lenabasum-open-label-extension-data-presented-eular-2019-continue-show-favorable-safety\" target=\"_blank\">longer term data</a> on lenabasum in mid-stage studies in systemic sclerosis (SSc) and dermatomyositis &#40;DM&#41;. The results are being presented at EULAR in Madrid.</li><li>Durable improvement in SSc, measured by a scale called ACR CRISS score, was observed from month 12 through 21. 81% of patients were still enrolled in the extension study at month 21. No life-threatening adverse events or lenabasum-related discontinuations were reported. There were seven serious adverse events, none related to lenabasum. A Phase 3 trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT03398837?lead=corbus&amp;phase=2&amp;rank=2\" target=\"_blank\">RESOLVE-1</a>, is ongoing. Preliminary data are expected this summer.</li><li>Sustained improvement in DM was also observed from month 12 to month 16, measured by a scale called CDASI. No serious adverse events were reported. There were seven (35%) adverse events possibly related to lenabasum. A Phase 3 study, <a href=\"https://clinicaltrials.gov/ct2/show/NCT03813160?lead=corbus&amp;phase=2&amp;rank=1\" target=\"_blank\">DETERMINE </a>is ongoing.</li></ul><div class=\"tiny-share-widget\" data-id=\"3470718\" data-linked=\"Corbus up 3% premarket on positive lenabasum data in rare autoimmune disorders\" data-tweet=\"$CRBP - Corbus up 3% premarket on positive lenabasum data in rare autoimmune disorders https://seekingalpha.com/news/3470718-corbus-up-3-premarket-on-positive-lenabasum-data-in-rare-autoimmune-disorders?source=tweet\" data-url=\"https://seekingalpha.com/news/3470718-corbus-up-3-premarket-on-positive-lenabasum-data-in-rare-autoimmune-disorders\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470711\" data-ts=\"1560342871\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CSCO\" target=\"_blank\">CSCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470711-ciscominus-1_7-on-downgrade-for-demand-pressure\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cisco -1.7% on downgrade for demand pressure</a></h4><ul><li>William Blair downgrades Cisco (NASDAQ:<a href='https://seekingalpha.com/symbol/CSCO' title='Cisco Systems, Inc.'>CSCO</a>) from Outperform to Market Perform citing tightening IT infrastructure demand.</li><li>The firm says the demand could put pressure on FY20 growth, especially compared to the \"unusually strong demand\" in FY19.</li><li>Cisco shares are <font color=\"red\">down 1.7%</font> pre-market to $56.16.</li><li>CSCO has an Outperform average <a href=\"https://seekingalpha.com/symbol/CSCO/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3470711\" data-linked=\"Cisco -1.7% on downgrade for demand pressure\" data-tweet=\"$CSCO - Cisco -1.7% on downgrade for demand pressure https://seekingalpha.com/news/3470711-ciscominus-1_7-on-downgrade-for-demand-pressure?source=tweet\" data-url=\"https://seekingalpha.com/news/3470711-ciscominus-1_7-on-downgrade-for-demand-pressure\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470704\" data-ts=\"1560342246\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBAY\" target=\"_blank\">CBAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470704-raymond-james-bullish-on-cymabay-after-overblown-sell-off\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Raymond James bullish on CymaBay after &quot;overblown&quot; sell-off</a></h4><ul><li>CymaBay Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/CBAY' title='CymaBay Therapeutics, Inc.'>CBAY</a>) <a href=\"https://seekingalpha.com/news/3470612-cymabay-plus-4_8-percent-raymond-james-fades-45-percent-sell\" target=\"_blank\">upgraded </a>to Strong Buy at Raymond James citing yesterday's \"overblown\" 45% selloff in reaction to disappointing data on seladelpar in NASH. Shares up <font color=\"green\">7%</font> premarket on modest volume.</li><li>Misonix (NASDAQ:<a href='https://seekingalpha.com/symbol/MSON' title='Misonix, Inc.'>MSON</a>) initiated with Buy rating and $29 (21% upside) price target at BTIG Research.</li></ul><div class=\"tiny-share-widget\" data-id=\"3470704\" data-linked=\"Raymond James bullish on CymaBay after &quot;overblown&quot; sell-off\" data-tweet=\"$CBAY $MSON - Raymond James bullish on CymaBay after &quot;overblown&quot; sell-off https://seekingalpha.com/news/3470704-raymond-james-bullish-on-cymabay-after-overblown-sell-off?source=tweet\" data-url=\"https://seekingalpha.com/news/3470704-raymond-james-bullish-on-cymabay-after-overblown-sell-off\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470699\" data-ts=\"1560341447\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NXPI\" target=\"_blank\">NXPI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470699-nxp-semiplus-2_6-morgan-stanley-leaves-sidelines\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NXP Semi +2.6% as Morgan Stanley leaves sidelines</a></h4><ul><li>Morgan Stanley upgrades NXP Semi (NASDAQ:<a href='https://seekingalpha.com/symbol/NXPI' title='NXP Semiconductors N.V.'>NXPI</a>) from Equal-Weight to Overweight and increases the target from $99 to $114.</li><li>The firm cites valuation with NXPI \"at the biggest discount in its history\" compared to its peers.</li><li>Analyst Craig Hettenbach also notes that NXP has \"aggressively\" reduced inventory in auto chips, which should mitigate lingering H2 risks in the supply chain.</li><li>NXPI shares are <font color=\"green\">up 2.6%</font> pre-market to $97.90.</li><li>NXP has an Outperform <a href=\"https://seekingalpha.com/symbol/NXPI/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3470699\" data-linked=\"NXP Semi +2.6% as Morgan Stanley leaves sidelines\" data-tweet=\"$NXPI - NXP Semi +2.6% as Morgan Stanley leaves sidelines https://seekingalpha.com/news/3470699-nxp-semiplus-2_6-morgan-stanley-leaves-sidelines?source=tweet\" data-url=\"https://seekingalpha.com/news/3470699-nxp-semiplus-2_6-morgan-stanley-leaves-sidelines\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470693\" data-ts=\"1560340404\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TTD\" target=\"_blank\">TTD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470693-trade-deskminus-5_9-nomura-questions-tam\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trade Desk -5.9% as Nomura questions TAM</a></h4><ul><li>Nomura downgrades Trade Desk (NASDAQ:<a href='https://seekingalpha.com/symbol/TTD' title='The Trade Desk, Inc.'>TTD</a>) from Neutral to Reduce on the lofty investor expectations for the company's prospects.</li><li>Analyst Mark Kelley says the fundamentals are \"relatively solid\" but \"out of sync\" with near- to mid-term expectations and \"the story being told.\"</li><li>Kelley says some investors see a $1T online advertising TAM for Trade Desk, but Google and social media companies have already claimed most of the total. Removing that portion, Kelley sees the remaining market growing to about $60B in 2021.</li><li>Kelley estimates TTD's revenue potential at $12B, roughly in-line with its market cap.</li><li>Trade Desk shares are <font color=\"red\">down 5.9%</font> to $234.70.</li><li>TTD has a Neutral <a href=\"https://seekingalpha.com/symbol/TTD/ratings/quant-ratings\" target=\"_blank\">Quant rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3470693\" data-linked=\"Trade Desk -5.9% as Nomura questions TAM\" data-tweet=\"$TTD - Trade Desk -5.9% as Nomura questions TAM https://seekingalpha.com/news/3470693-trade-deskminus-5_9-nomura-questions-tam?source=tweet\" data-url=\"https://seekingalpha.com/news/3470693-trade-deskminus-5_9-nomura-questions-tam\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>67&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470690\" data-ts=\"1560340042\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BYND\" target=\"_blank\">BYND</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470690-beyond-meatplus-5-after-tim-hortons-roll-out-in-canada\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Beyond Meat +5% after Tim Hortons roll-out in Canada</a></h4><ul> <li>Beyond Meat (NASDAQ:<a href='https://seekingalpha.com/symbol/BYND' title='Beyond Meat, Inc.'>BYND</a>) gains after Tim Hortons <a href=\"https://www.newswire.ca/news-releases/beyond-meat-r-breakfast-sandwiches-are-now-available-at-tim-hortons-r-restaurants-across-canada-827519589.html\" target=\"_blank\">announces</a> that Beyond Meat Breakfast Sandwiches are now available at almost 4K Tim Hortons restaurants in Canada after a strong consumer response to testing.</li> <li>Shares of Beyond Meat are <font color=\"green\">up 4.73%</font> premarket to $132.00.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3470690\" data-linked=\"Beyond Meat +5% after Tim Hortons roll-out in Canada\" data-tweet=\"$BYND - Beyond Meat +5% after Tim Hortons roll-out in Canada https://seekingalpha.com/news/3470690-beyond-meatplus-5-after-tim-hortons-roll-out-in-canada?source=tweet\" data-url=\"https://seekingalpha.com/news/3470690-beyond-meatplus-5-after-tim-hortons-roll-out-in-canada\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>44&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470685\" data-ts=\"1560339547\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LRCX\" target=\"_blank\">LRCX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470685-lamminus-3-evercore-sees-recovery-delay\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lam -3% as Evercore sees recovery delay</a></h4><ul><li>Evercore downgrades Lam Research (NASDAQ:<a href='https://seekingalpha.com/symbol/LRCX' title='Lam Research Corporation'>LRCX</a>) from Outperform to In-Line and cuts the target from $225 to $195.</li><li>The firm sees the memory recovery as pushed back to H2 2020.</li><li>LRCX shares are <font color=\"red\">down 3.1%</font> pre-market to $184.</li><li>Lam has an Outperform average <a href=\"https://seekingalpha.com/symbol/LRCX/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3470685\" data-linked=\"Lam -3% as Evercore sees recovery delay\" data-tweet=\"$LRCX - Lam -3% as Evercore sees recovery delay https://seekingalpha.com/news/3470685-lamminus-3-evercore-sees-recovery-delay?source=tweet\" data-url=\"https://seekingalpha.com/news/3470685-lamminus-3-evercore-sees-recovery-delay\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470683\" data-ts=\"1560339470\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BTI\" target=\"_blank\">BTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470683-british-american-tobaccominus-5-after-trading-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">British American Tobacco -5% after trading update</a></h4><ul> <li>British American Tobacco (NYSE:<a href='https://seekingalpha.com/symbol/BTI' title='British American Tobacco p.l.c.'>BTI</a>) <a href=\"https://www.ft.com/content/20fc0c50-8cdc-11e9-a24d-b42f641eca37\" target=\"_blank\">warns</a> global cigarette sales volume will fall around 3.5% this year, driven lower by a 4% to 5% drop in the U.S. market. The tobacco company previously forecast a 3.0% drop.</li><li>BAT says it's on track for constant currency revenue growth in the mid-upper half of its long-term guidance range of 3% to 5%.</li> <li>Due to weakening cigarette demand, BAT plans to invest further in what its New Category business and announced plans to consolidate the portfolio, which included Vype and Vuse vaping pens.</li> <li>\"We are creating a stronger, simpler business and driving a step change in new categories, built on the foundation of a strong combustible business,\" says new British American Tobacco CEO Jack Bowles.</li> <li>Shares of British American Tobacco are <font color=\"red\">down 4.77%</font> in London trading.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3470683\" data-linked=\"British American Tobacco -5% after trading update\" data-tweet=\"$BTI - British American Tobacco -5% after trading update https://seekingalpha.com/news/3470683-british-american-tobaccominus-5-after-trading-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3470683-british-american-tobaccominus-5-after-trading-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>46&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470679\" data-ts=\"1560338655\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVS\" target=\"_blank\">NVS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470679-novartis-cosentyx-shows-sustained-benefit-in-late-stage-psoriatic-arthritis-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Novartis&#39; Cosentyx shows sustained benefit in late-stage psoriatic arthritis study</a></h4><ul><li><a href=\"https://www.novartis.com/news/media-releases/cosentyx-provides-long-lasting-inhibition-radiographic-progression-psoriatic-arthritis-new-novartis-data-show\" target=\"_blank\">New data</a> from a Phase 3 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT02404350?term=future+5&amp;rank=1\" target=\"_blank\">FUTURE 5</a>, evaluating Novartis' (NYSE:<a href='https://seekingalpha.com/symbol/NVS' title='Novartis AG'>NVS</a>) Cosentyx (secukinumab) in adults with active psoriatic arthritis (PsA) showed a durable treatment effect. The results are being presented at EULAR in Madrid.</li><li>Almost 90% of treated patients showed no radiographic progression over two years. Over half achieved ACR50 (50% improvement in arthritis) while almost half achieved completely clear skin (PASI 100).</li><li>Secukinumab inhibits the pro-inflammatory cytokine interleukin 17A (IL-17A). The FDA approved it in January 2016 for PsA and ankylosing spondylitis.</li><li>Shares are up <font color=\"green\">1%</font> premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3470679\" data-linked=\"Novartis&#39; Cosentyx shows sustained benefit in late-stage psoriatic arthritis study\" data-tweet=\"$NVS - Novartis&#39; Cosentyx shows sustained benefit in late-stage psoriatic arthritis study https://seekingalpha.com/news/3470679-novartis-cosentyx-shows-sustained-benefit-in-late-stage-psoriatic-arthritis-study?source=tweet\" data-url=\"https://seekingalpha.com/news/3470679-novartis-cosentyx-shows-sustained-benefit-in-late-stage-psoriatic-arthritis-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:24 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470678\" data-ts=\"1560338642\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/COMM\" target=\"_blank\">COMM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470678-commscope-juniper-gain-on-rosenblatt-upgrades\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CommScope, Juniper gain on Rosenblatt upgrades</a></h4><ul><li>Rosenblatt upgrades CommScope (NASDAQ:<a href='https://seekingalpha.com/symbol/COMM' title='CommScope Holding Company, Inc.'>COMM</a>) from Neutral to Buy but reduces the target by $2 to $22.</li><li>The firm also upgrades Juniper Networks (NYSE:<a href='https://seekingalpha.com/symbol/JNPR' title='Juniper Networks, Inc.'>JNPR</a>) from Sell to Neutral with the target increased from $24 to $27.</li><li>Analyst Ryan Koontz notes the rising wireless capex ahead of the 5G build.</li><li>COMM shares are <font color=\"green\">up 2.8%</font> pre-market to $16.98. Juniper is <font color=\"green\">up 0.8%</font> to $27.15.</li><li>CommScope has a Bullish average <a href=\"https://seekingalpha.com/symbol/COMM/ratings/author-ratings#filter=all\" target=\"_blank\">SA Authors' rating</a>. Juniper has a Hold average <a href=\"https://seekingalpha.com/symbol/JNPR/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3470678\" data-linked=\"CommScope, Juniper gain on Rosenblatt upgrades\" data-tweet=\"$COMM $JNPR - CommScope, Juniper gain on Rosenblatt upgrades https://seekingalpha.com/news/3470678-commscope-juniper-gain-on-rosenblatt-upgrades?source=tweet\" data-url=\"https://seekingalpha.com/news/3470678-commscope-juniper-gain-on-rosenblatt-upgrades\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470671\" data-ts=\"1560337770\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FTCH\" target=\"_blank\">FTCH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470671-keybanc-joins-bull-camp-on-farfetch\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">KeyBanc joins bull camp on Farfetch</a></h4><ul> <li>KeyBanc starts off coverage on Farfetch (NYSE:<a href='https://seekingalpha.com/symbol/FTCH' title='Farfetch'>FTCH</a>) with an Overweight rating.</li> <li>The firm assigns a price target of $29 to online fashion platform the to rep +25% upside potential.</li><li>On Wall Street, 10 of 13 analysts covering Farfetch have Buy-equivalent <a href=\"https://seekingalpha.com/symbol/FTCH/ratings/sell-side-ratings\" target=\"_blank\">ratings</a> on the books.</li> <li>Shares of Farfech are <font color=\"green\">up 2.62%</font> in premarket trading to extend on yesterday's 6.87% gain.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3470671\" data-linked=\"KeyBanc joins bull camp on Farfetch\" data-tweet=\"$FTCH - KeyBanc joins bull camp on Farfetch https://seekingalpha.com/news/3470671-keybanc-joins-bull-camp-on-farfetch?source=tweet\" data-url=\"https://seekingalpha.com/news/3470671-keybanc-joins-bull-camp-on-farfetch\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470668\" data-ts=\"1560337597\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTRV\" target=\"_blank\">CTRV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470668-contravir-files-for-equity-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ContraVir files for equity offering</a></h4><ul><li>ContraVir Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CTRV' title='ContraVir Pharmaceuticals, Inc.'>CTRV</a>) has filed a <a href=\"https://www.sec.gov/Archives/edgar/data/1583771/000104746919003570/a2239011zs-1a.htm\" target=\"_blank\">preliminary prospectus</a> for a public offering of ~2.9M Class A Units, each consisting of one common share and one warrant to purchase one common share, and 20K Class B Units, each consisting of one share of Series E Convertible Preferred Stock (valued at $1,000) and the equivalent number of warrants if the purchaser had bought Class A Units (based on the conversion rate).</li><li>Prices and terms have yet to be announced.</li></ul><div class=\"tiny-share-widget\" data-id=\"3470668\" data-linked=\"ContraVir files for equity offering\" data-tweet=\"$CTRV $HEPA - ContraVir files for equity offering https://seekingalpha.com/news/3470668-contravir-files-for-equity-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3470668-contravir-files-for-equity-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470666\" data-ts=\"1560337370\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADDDF\" target=\"_blank\">ADDDF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470666-adidasminus-2-after-top-investor-pares-stake\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Adidas -2% after top investor pares stake</a></h4><ul> <li>Adidas (<a href='https://seekingalpha.com/symbol/ADDYY' title='adidas AG'>OTCQX:ADDYY</a>) falls after trader sources indicate that Groupe Bruxelles Lambert is preparing to <a href=\"https://www.reuters.com/article/us-adidas-gbl-stake/adidas-shares-slide-as-traders-say-top-investor-gbl-to-cut-stake-idUSKCN1TD0VS\" target=\"_blank\">sell</a> a portion of its ~$4.5B stake in the German company after seeing the share price hit an all-time high yesterday..</li> <li>GBL is said to be slicing 1.37M shares off its total position of over 13M shares at a deal price of \u20ac257.75 per share.</li> <li>Adidas is <font color=\"red\">down 1.61%</font> in Frankfurt trading to \u20ac255.85.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3470666\" data-linked=\"Adidas -2% after top investor pares stake\" data-tweet=\"$ADDDF $ADDYY - Adidas -2% after top investor pares stake https://seekingalpha.com/news/3470666-adidasminus-2-after-top-investor-pares-stake?source=tweet\" data-url=\"https://seekingalpha.com/news/3470666-adidasminus-2-after-top-investor-pares-stake\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470657\" data-ts=\"1560336604\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NEPT\" target=\"_blank\">NEPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470657-neptuneplus-8-premarket-on-services-deal-green-organic-dutchman\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Neptune +8% premarket on services deal with The Green Organic Dutchman</a></h4><ul> <li>Neptune Wellness Solutions (NASDAQ:<a href='https://seekingalpha.com/symbol/NEPT' title='Neptune Wellness Solutions Inc.'>NEPT</a>) inks an <a href=\"https://seekingalpha.com/pr/17541862-neptune-signs-multi-year-extraction-agreement-230000-kg-including-turnkey-solutions-green\" target=\"_blank\">agreement</a> with The Green Organic Dutchman Holdings (<a href='https://seekingalpha.com/symbol/TGODF' title='The Green Organic Dutchman Holdings Ltd.'>OTCQX:TGODF</a>) to provide extraction, formulation and packaging services.</li><li>Neptune will extract and purify cannabinoids and terpenes from cannabis and hemp biomass received from TGOD. These extracts will be transformed into premium certified organic finished products.</li>                    <li>Under the terms of the contract, TGOD will supply more than 230,000 kilograms of cannabis and hemp biomass spanning a three-year period.</li>  <li>Neptune will also formulate and package for TGOD capsules using its Licaps technology licensed from Lonza. Health Canada is expected to authorize the sale of new product forms, including vape pens and infused food and beverages in fall 2019.</li>  <li>The first shipment of biomass is expected in September 2019.</li><li>Shares are up <font color=\"green\">8%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3470657\" data-linked=\"Neptune +8% premarket on services deal with The Green Organic Dutchman\" data-tweet=\"$NEPT $TGODF - Neptune +8% premarket on services deal with The Green Organic Dutchman https://seekingalpha.com/news/3470657-neptuneplus-8-premarket-on-services-deal-green-organic-dutchman?source=tweet\" data-url=\"https://seekingalpha.com/news/3470657-neptuneplus-8-premarket-on-services-deal-green-organic-dutchman\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3470656\" data-ts=\"1560336548\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SYBX\" target=\"_blank\">SYBX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3470656-ginkgo-bioworks-to-invest-80m-in-synlogic-premium\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ginkgo Bioworks to invest $80M in Synlogic at a premium</a></h4><ul><li>Synlogic (NASDAQ:<a href='https://seekingalpha.com/symbol/SYBX' title='Synlogic, Inc.'>SYBX</a>) and Ginkgo Bioworks announce a platform collaboration to accelerate expansion and development of Synlogic's pipeline of Synthetic Bioticmedicines using Ginkgo's cell programming platform for building and testing microbial strains to accelerate progression of early preclinical leads to drug candidates.</li><li>The agreement provides an $80M equity investment at a premium in Synlogic by Ginkgo and entry into a long-term strategic platform collaboration. Ginkgo purchased 6.3M shares of Synlogic common stock, and warrants to purchase up to 2.5M shares of Synlogic common stock, both at a price of $9/share. SYBX closed yesterday at $6.27.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17541863-synlogic-ginkgo-bioworks-establish-transformational-platform-collaboration-accelerated\" target=\"_blank\">Press Release</a></li><li><strong>Update</strong>: Mid-session, shares are up <font color=\"green\">28%</font> on a healthy 33x surge in volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3470656\" data-linked=\"Ginkgo Bioworks to invest $80M in Synlogic at a premium\" data-tweet=\"$SYBX - Ginkgo Bioworks to invest $80M in Synlogic at a premium https://seekingalpha.com/news/3470656-ginkgo-bioworks-to-invest-80m-in-synlogic-premium?source=tweet\" data-url=\"https://seekingalpha.com/news/3470656-ginkgo-bioworks-to-invest-80m-in-synlogic-premium\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}